var title_f24_19_24880="Portable hyperbaric chamber PI";
var content_f24_19_24880=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F54655&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F54655&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Portable hyperbaric chamber",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 260px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0+3KSMQrDPoRU21EPYE9SKoRn/WPt5PTBqeCJiD5h256ZPNaexkb8yHpKrZ/djcO5706Pfgbguc9KqSm3gkWKSbLseBnvT1yFRJXCc9QaPYyGmiWV1hjd5PlCjNQLdBsGPqRxSoYZUkCP5zn5cU9YQrplFBA7UexkO46N5HuVDfcxzxVrfHuCEgE02eVYUHykk9qr3FsZlGCQD6UexkBcDbHwoGO9HmFn4GF9aiSExgDJOFA5oUssbE5GDxR7KQXROVLNtJH0xTlhx90c1VErl8knpxUnmbhktg0nSkFyyrGPIbGe9PWfyhnIINVonVgUYjJ/OnJ8oxs74zS9lICVpGkYEcE9KcTnac8DrR95OBgiklOYisYw1L2UhEhAJBCgg96YSfMwuSR+VOhdliXeORQJQGBAALU/ZyC4iKWyR+NLECh+YgelSJGvmN2OM5pTGrqAGz70nTkCkiPnfknH1qKSORzkyEDParKxkDZ1HY0+NAuQeTR7OQ7ohiUxIwJz71MDsw27tTHlXzTE6nJHapPLAxt6Y6U/ZyHcaxSQ8Y3etNk37du9cepqRoAw9DTWskYcsRR7KQXKoaSFQjeZITzu4FW1jbgbsAjPPNSfZh9mIncKu3lvQVLbxxJEojfegHDetHspCuRxxM2QXXjpxSGI9nz9KkMbu5CHFSR2/lpk5LE9aPZsLlTy2Y7cGlW3Xr6da0tm1dxIzUEhwwCkc0ezYrlWOJvlAkUc+lOlIjxv5OO1DNISp4ADU1xKDjqM/pR7OQXuN80PGpQ/N64pI13cu2T2qQqACewpVKAYPaj2cgIXjBA9aUQKSOnqM1M43D93waaeRtPUUeykIqbHMxPAU9cCiVfK+4QoPc1NNhUwQ2R0xUMkZkVCAODzu60/ZyC5G0pRCWckDrimJMJU3RnIPQmrghVt4jQDjnNQhEjkKqApPaj2chcxCpNrHtZ0DOcA4pwjCYaSZc9xTnQEZcFj0z6U0QNv2yKGQ0vZyHzE6svzY2nPtUbbXO0ADHpTWDIXVFPPSlkhaSBQXwRzxQqcg5kTj5QAoyc8U9ivBAwR1NVY1ePADEg9c1HNKznLLhugPaq9kwvcfPOQ25Tj3Iqk32ia6UyS7VHQL3q8oMsQV5BkdcVGypFKAWzn17UeyYXIGgjWYtht3qTUaqWJAYn3FWpsOdv8PrSpGsK9Fwe1P2UguVY7WXvIGX361FJCIX3LyTxirpkQEMowT2om+7kMNx7U1Rb6hcwZNoBVB82M8Uz7STHiThz+lXo0jV2L8Fh1PakdVYZ2gkHsM1jzyKsirFAGnUsod+zEc1bazLksx5pzyFHRmj2r0GBUtxdiOEssbMx/h6Uc8hlYW3krm2j2e460qxSnDDdnPJNPaVmjU7WGRnr0pySRkKzvJn0HSjnkAo85sknO3oKsINifO4FRPJGQfL3c+pqGONUBYvk+p7Uc8u4FtW38g9KchzIo7YPFUg3zfK2R7VIk+FLY5AwBmlzPuLlLwUYUnmmtGjHIHPpVZZSIlbPJ6ClM8isGx2xihyfcdrCNZ/vdx4LDg1IpmiXBGSOAPeorT7TlvOkDgnK8Y2094pjIQcknow7UrvuA8zSRlQUYsetTqQVY7ieO1V4hJESZG3Mvc96lEp37QBjHIFPmfcBtpLPJGxkQqAcDd3HrUw2nap2ls9KrJcPMGAU7YzjNRx4M3mAblHbNK77jNLzCcgDIIxnNECCIAbiQexNQoGQAIoAPrU38W0j8aV33FuTbz0ycCnK6nO7rUK/KwBOQakwj9F5p3YWFO0PuXeQo5CnrUVnN9qjZ490QViNrdasKBG/DYJ7ipFZVJJUnPU7eKLvuIezBUUrgkj0pudyZJpTInYD2pFUdz1/SnzPuBHKYJYnRyzqwwQKW3jEMCxRDCr90elSxIvzNtH4cYp+xVUFeCe+etJt9x7iLlkIU7W9u9JOBJOhE0ihRyoPBqK4cxRswwW7c4piu7YJ2j8aWvcLInmd+Ap6+tRry+BncO9MfLqMHP07VHJ5zRsqOFOOuKNe4ySYMx4OAPSkUt5ZO48VGGcIgZskdfenMCUbBwCfyou+4hMkcl8Ajv0oVlHzb9x9qTAZioIO0fnQ4jwCQFNF33CxKR8wwx5pjMSfm6jofWoDIVcZUlcZ3CpT88fyKS56H0p8z7isOeXI+bcM9cVEZFK8BgBzn1pIlbaVlfc3fjFTKpYYC8D3o5n3ARHBTIU5pjjOGZQT71MG2g8AfrUTMzfMcY7Ucz7h8hCecdAe1BXbw34GopX+UscDbzjNNjn3om8ct05o5n3D5EzStnBXNKki5PzbT6GqsgAm3JuA9CasxxKw3cfzoUpdwsiMCUSn59+exqTy96r5vA9KUybGAK/j6VLJKmUWhyfcLEEqRrIRHxmq80DeZuL5GO/NW5GjLSDvjrVO6nhhRcsxL8ACjmfcLDGUryGBHpmjyd4VnOcVWV3d3zDtRTwS2c1IZizeWD94demKPaeYWHeW0fAGV5IJNRthwpGd+KayxJIN8rswGODwaTzlVTgE01MOUpR72VVcean9496likjSPcGIPtzVVLQTrBI0ssSxngAjBq03loASRjOOO9ADpL9QBt+bdwDjvR54cDecEe1MKR9AuMHNMfb5Ss3PNA0SxNgtiUYB4BpjFmJ2hmGe1VYHgknaMBiQOp4q4k6qgKgqqjBOetAyOVJAu5UIx781RinuHD/utoH9+tBrpDA7hwRjj1FVTqcCI0jQylQBliKAJo5CEUgckdqtxRlickYIqISQShXRvlYbgB6VKJpCpjEQCnox61IXJFhwy7Dn61MSIwNwyaz3dg/lbmjU/xYqSHIyA5kI9aBMuidWYAK2fpUzM2flDZrNe+S1aNJFfzJOm0ZC1aEo7NJu9cUCHmVRkSMqsezdaSUoSUaMkt/EpqPakkv7xGZvUil2uc7vkUdMUxhZwQW5dYlcBvvZPepXWKFQucHPamLkAZH60tvGJcllHB45pATRzxPxvGR71JvBACkGo44ozMSsQGOvFWEEZBCpg9qAGrIyyFNhPHpT1Z1QkjHNLAJAd7nkVK/II7mgBYwrbWB/OmOHdjgcexqvdrN9nk+ysI3A6nnNTWvmvGm4/vMDc3TNAALVim8swAOcVIm8oWRhzTt7DqxA6GieYQxbwPkHXAoBgvmRliZAzEdPShpNmwN93HOPWoy+QXDH5h6U3LhFxz+FAIbcJ5+Q6Ar255pI4NqDadv41LGz5+bj8KcAGyuOaYCxxCMktNkmkkjHGHJqOQbdoA570EjOTwBSAEMbNhs/WnCJFGQ5bnoabvj6AHJp20P35oAGQLnA2g0yQZUADcvvUjhs5JyBTN34CgCP96qFegzjilChgd7FV6cGnLLGykK2AOtRLGVJGd6P3NIAKJnKsQPenligG0k+1NeL5htORT0UjgnA9aaAHnCgAjBqKSRR8y/ex/FxmnSqG7A47imLHG+AfmI9aAKyO11ES+6Jt2OO9TAFhEGwwQ+ozTzCN43Hp0FMVcFXIwM9aAH7D1wacpd+OgHPpTHJ2ttJZhnpUcLXQb95goanUCbeWY96kdQwBzSbQOeg9qikYKgKAk5oQMS4YqWwMcVWB83apAyKsOzNF8y980DaTuIAIFMEMEQ5U5JHeoZmVHEaqSx6npUrXQ3EFeOmfSmIQFJzuNHL1KIlZCceXgipJANmdmMUk08EcTF2QA9OeaopfASbSrsAN249PpTsIrs5QKmVwecE1BdSKkRY5J3Z2gVDcsj3GJUPH8VPhKIT+/R1HRc5NdKoSsTfU0ILiJ4xu+XjJqPcsjYUgoKYsaum5eAfWlGyIAFc571Psmtx37EkiqAxAO/1rNnjZnTYWKD7wqbUr210+2ea6l2Knvya4PUPG13LKy2UaxR9A5HJ963pYGpPYxqYiMNzvLdkjQlgApP8AEcVJ5yMxyQyntkYrxm71DULpx591I3OcA4quLm6j5S7nH/Aq61lUmtZI53j4roe5wPG+VQKhH0q0HyAVOccdc14ELzUOSL64DH0ep4tY1SHAj1C4GP8Ab60PKJdJIFjo9j6ATdwuwY96G+UHpk+grxKLxdr0ZH+mZA/vDNWI/G2tq2TPGx/651H9k1ejQ/rsGewxkKUyuSPUVMZ+GA6+9eOnx/riuCHhyOv7sUh8d62zbvMhB68IKX9k1u6D67A9ettQdw6iNiV7nIqykpJUun/Aa8W/4TzXsNieIA9fkpYviBrp2jfASO+wU/7Jrd0H12B7O7rJKVCEH1xxUkKIvAGB1NePH4ia0VwRBn1Cdali+IuqrgtFAT9Kh5XW8ili6Z7OHQkFTjHWnGSNWXjnsa8ht/iZfLxJaQt+NWF+J0wJMmnoQOBh6X9mVluNYqmesytuc8cEdqQvjACmvKYfiY6ly1jkntv6VKvxQcHnThj/AHqX9m1R/WqZ6htbqMYPaps8AFcAdxXlp+KgyANN4/36lX4pxhiZNPfb6Bs0v7PrD+tQ7np23PzKRj1NMZlCkls+orzyH4o2GPnsbgew5qYfEzSGcB4rhB6YpPAVV0D6zDudoiHZyxPNTbTwcHjpXIQfEHQJAc3Ei56ZSrcXjbQz8p1EJ9RUfU6nVFqtB7M6VyWK8svtnrQGKucBR+NYcXijRZOP7Vtyp9Tg1OuqaRcYKajAWHo9S8LNB7VGiZMNhvl9acsqNgOnHr61XF5aODieF89MNTiVYAxsCD2zUewl1K509mWDIhZcKPSk2YfBYE+xqqyyFmxjaRxzVaCGSJ9zSk/Wj2Xdj5u5pFlDcHApHaPGfvfSmKdy8gFfWkKnogx71Psn3DmI2t0kkEgGD9cU5wVK88ipUVv4xke9KVTcQ34Uey8wuMbp14zTXJ8wgEBcdKUrkDbzUUuOGLDIPQUey8x8xKuCOP0pjIABuBA7GmxlkLFyAKDMJAIznAo9l5he49cknuDx9KbCYn3JGS7L1FOhxzsPTsacoWMMyoqlupFHsvMCMBVDAkgkdqPlKIF+b1w1MlecSqsUatFjBYmhLWLeZBuMhXHB6Uey8wuIkrtK6CJgq9GNK0ZIABIPWj95FESAxYA8HvTbaZpRH5g2sOGo9l5iuyUKSAWXI9c01o1YFsnaP4fWp9q5Ko3HtVa4tm81HSR/l7Y601R8wuxrvEqYfhf7pFVJIkMm6NiMds1bkVpCfMXjHWmuscSEkHBGAQOar2XmF2UjZxEETR8Hkc1IluixKFYcdjVkKksaZckj1pTGqFio68DNHsV3HcypVXBDQ7w3U1mPotvLOJYt0cgPTNac1wFQMVIY8cVWmaQ/NCQPrWCfRsdrse9p8vEjn1rK1y9ttGtGluZGYsPlX3puo6y1m22VcoBlmQdK891i/fVL1pZ5WaFfuA1rCMY+9N6AqdStLkpK7KF9qE2p3Ty3DOwJ+6x+Wm+VycjHpTDNbo2TIAtRyarZxkES5x6V7dOouROOx5VajKNRxnuicxAnNIYAaqtr9gM5cnPtTG8R2AGBn8qt1E+pl7MtG3INKtsazn8S2faMn8aZ/wAJTar/AMsjS9ou4KkzY+z9OKTyRnpisdvFsBIxCajbxZCD/qRn60vapbsfs32NprYlyetI1q2BtrDPi1d3+oGPrTv+EsXbkWx/On7aIvZPsbH2MscnpTltsPWIPFhKcWbH8aafFYPS0el7aIeyfY6IW4GS1NEIDdM5rn28Vv1Foce9IPFch/5dD+VHtY9w9k+x0ZhAGdtAiBwccVzg8VTZ+W2b8qP+Eql5zatke1Htl3BUmdC1vtxuz+FDWwbBXdxXPDxW/VrN+falPi3aebVh+FP2y7j9kzfaEg0hiycHNYD+Lkz/AMex/Oj/AIS2M9YGFP20e4vYs3vK5x81NMXz/dz9axP+EstsYaJhUieK7U9Y2UepFHto9xexfY1/LwSAOnvQw2jlDg81kr4oss8qw96kPiTT2wSWzQqse4/ZyL/GcAt+dBwOhcfjVH+3rBj94g1KNTsn6SDn3p+0h3F7ORP5rg/JKy4/2zViLU76M5i1C4HsrVRF5ZklRInHvQJIGPyMv4Gq9172FaS2NqPxLrcYwuqXAHuavWvjjXYDuN35o/2xXNAp2cfnTWH+2TQ4U5dBqpUh1O8t/ilqUQH2i3hkH+yK2rH4q2Zx9rs5UJ/u8/pXkci5ORmkC8c/rWEsJRluarEzR77YfEDQbpebwxN/dlXAres9Z0++Ae3vYZPYOK+Y32gcgUiStC4aJmT3ViKxeXQ+yzSOMa3R9Rzy4+536YqAys4KGPaQM59a+drHxFqlm2631CcFegJyP1rpNP8Aibq9sR9ujju17k8HFc9TL5x1TN4YuEtz2fy9yth8nHQ9qI42XJLBmHXFee6b8TdLuVC3UU1u5PXqK66y8Q6ZeoPs19Ccj7rEA1xyozhujoU4vZmzEPm+YYJqyyrgBulZ8UmVz5gIPQqc0puvL+RmIHrisy7FwFCNp3KlKsaAYUMPeqTXC5JGQT0pI7mTJBOc0W7gknsaHHTkj1pGiUHdj5TVRZHK4bpT1lZWznijRCsSGMo3yEUxyVYk9+uaRpN3zDqKhmd2ZDuAHOaQ0V7qYrciPyGMR/iB6U8y/LjFPASWM7myQaSSJcr5agMOvNMegxTJgAj8aJQScqxBFVxORcGLaSo5zVncGHPUjkUWQOJln5ZAp5PSqriZJHmmlVIFUsdw4FSRTNtAlKpJ7da5L4hjWRpypokLXfmNiVc8gY61LbWiHDllJKT0MXxT4riLi105cmU4eRuhHoKw75JIbErGSZWB6isKzt5/NEuoqVnj4CA8Kc1sy3xmbDkZAwDQ8DWq8rlsetDNsHhYVKdFa9HrqYCaBcTIBNOw+lW4vCsHV5XPGDWkZ0AyDk+masRTrt4zXt8mnkfIucm733KMXhjTwBv3t+NSp4a00N/q2P41fWcHoOanjlB6daOVdhcz7mcnh3TlP/Hvn6mpV0HT1IxbLV8S81IkwweM07eQ7lL+xdO4/wBGTP0py6NYZ/49Ij+FWxJnnFSJJkcdaOULlM6RY54tYx+FTJpVn91baPp12ircb4+8Kcsgz6UcoXKo062AwkEf/fIp32C2x8sMf/fAq4Hz0GKVgo6GptqFyh/Z9uQQYUP/AAEULp9uvSBM+6irvJ6cUoVuMkYqrBcp/YIcZ8mMf8BFILGHg+Un/fIq+qk5FHlNj0osFyn9jhY8xqMf7Apkmn2z9YYz/wABFX9khIGQaGSRSNu080WQXMz+yrMk5tYv++aP7Ot0GFtocf7grV2SliSFFRtC7HJ/Sq5UK5mHTrdj/wAe8IP/AFzFK9hbsMPDFj/rmP8ACtURkJlQM+9MIk7Kpo5V2Fcwn0HTnPNvH+VRyeHNLcc2icdxW+28dIwaiZpM/NCT9KOVPoFznT4W0xgR9n/WoT4S05TkRP8AnXSNIQw/cuKTzh3ien7PyC5y8nhGyfJUSIfaq7eE7cDi5lBrrjcRgE7WyexqM3EJHQZ+lHs12FzvucZL4UIPyXb/AJmov+EbvF+5esT7mu3DwH7xz+FIY0LZUpT9mkHOzgn0fV4ztW4BFNFhrKD/AFitXdtGD12/hUTwZ7UcnmHO+xwjf2zGcGMMPwpPtl+qbZrUnmu0e2OeB+lRSW5IztGaXJJbSDn7o5H+1njx5tu4/ClGrwnna649RXSPbAZ3KpJ9ulU57CI53opz6VfvpbhzR7GQmoW7qcuefWnJfQI24S7T2IODVt9NtSOYyKrto9sTu2nAo5qnkxqUTSstfvoXVbO/l3dlDk10mm+PtfgcRTv9o9FkXBx+FcZpcWn6Vq0N3eg7V+4B6+p9q6bS7w311dXRETQiUiF1H3lrgxdVUaTlKOp6mWYR4vEKlGWh6Do3xEs7mNf7Wt3s8fx4JWuktfE2i3m37NqEXXucV5jMVeA/Irf744rl9VfT4HBldIZP9g4FeTSxFGr8SsfQ4vI6tBc0Jq3nZfnY+i4763uJNkU6Mx6bWzUx3gBSDj1r5otrm5jJm029lOOjI/IrTs/FfiK1kBW5nkx/f5FdioQkuaM18zxJUa9N8rpv5a/kfQbyYZUQ5cnkGmT58t1wS/YGvJ9L+Jd4hCa3aZToJYxg16LpWsWur6fHdWU6MgHI3fMPrWTpvo7hKM4/HFr1Vi1BHMIysvy57rViNNrbUb5/eoRd4QEd/WpbecynOwKw6e9RyiI7hxGkYYtlifuimyW7eaHZiU9BVwSIJgCqlvSop5Bk/wAPPejYHIoxwNySihR3qtNPCsNw+MMiEnd3OKVLkCRI0BKgc571ja4ZDpOpyvIDiI7V9K3jTu0mzKcrR0PHruU3F3LK3VnJwPTNNDRhvunNURMNo35HpURnIOVavaUEklc8zV6mrvUH5R+dSrcbTjisIXaM3JIpyXQX7rEijkT6hZo3luzyAanF0AvDc1zYu+eKlW6Pc0eyj/MFzpYrzd1qT7So6NXOrdlRyc05bksfvGj2Uf5gudLFdIepqdJVzlQMfWuVa6AGM9au21zgAE5GKTpLpILnSpOPwp/mdxXPx3m3AJytWkvQR1wKPZf3g5jaSWpQ465zWJHfqxwDVqK7Q9Kl0v7wcxpiQNT0OWHpWcs/PDVKlyAQC1Hs1/MO5oqQDTgRnrVJLhSefzqWOaPdRyJdRotgj0p24E9KiWZedv60qyrnmjl8x6k+AaTYKaJVzTxKntS5F3APKy3AyKd5QPHl4oEoxgU8NnvRyLuFxnlr/dpPLXPC1Y+XHWlDKCO46U+SPcNyq8J67Rio2hB6KK0CFPBA45pGSMDIwDRyx7i5TOMK9PLGKje3jx/qlrQAHTApGXbQku4uUyzaxH+BBUL2cZ6IorWYZ7VGcbcAc1aS/mE4mRJZoOBx9Khls8jAZl9xW0yr3AqIqvfpRZfzC5Tn5dPm6pM9QNZ34GUdSPeukaJT6U3yd5wq7vxqrxiruSHGDm7RRy5hvgeY1GP1qCYXI5a2DYrtF06WTqoQe9JJoxAJLpmsZYrDrRyOyGV4qovdh+RwUkzj78BX8Kia5ULjBA+ldzNopKZyrH0FY95ppQnzIRjPpVQxOHlopE1ctxVJXlA888USxssCqxyMnFavhy/mt9MWOMjg55rI8WhP7SEaDaqL0rV0O1hfTI3b7x6modKnVqOM9UTTq1MP79J2Zo3OoXMqeWD5SnsKxbnToiS8kYkJ5yx5rTktFUjZIxqrJFKjHBJWto4PDxWiQquNr1v4kmzOhgktm8y2cx/jwKkk1vU7YYISRfpUx46g49Kq3I3dqxq4GlI2o5jiKNrT0JIvEjyELcxIB9KNL1i4s7wvYStEc7hzxVJ4o2IyBkDvUTxBG3dPpXNRwcaT3NsTmdXFQUZu9j3/AOH3jKHXLb7NeyQw6hGOIz/GPWu7EgALEqABnpXyl4fvJbHXbO6gy7CVQQfTPSvrBCZIUdlTEiKSB05rGtQpp72FSqcy1GzJJNFutSofIOSKeJP3hinTLY+8V4pXyw2R4DDiq9pFcIHSeTOWyO9ZqlB7s0uzLurlEHyjZngNisHXYmudMuVS4RCUIIYH5zjoKmtomAWKa7E7k7wOm2pZhD5kckyCQg7gM8ZrlTtK43sfO80jW88iOx3K20qexqOWViM8/nXXfFLRVt75NT0/545yRIgH3W9a4FJC6kqSSO1d8a1zicLMt/aDnOKBcEA8VT8ylWQHrTVR3sTylxLgn61Mk59azi46DrTkc+tV7Rhymj9obGSc81MtwelZivubHpTlmGMGtFMmxqeduYc1cjuNpHP4VhpKFPB5qZJz361amhNG0LrbwQcVOtzwOc5rBE5LkN0qeOUZ+U9KvnQrG0k+x+5q0lyMZDVgrKSc5qWO5YHGBRdMLHQJd7mABP1qzFcZPzGuaW5Yn0xU8N2SeT0pOMegXsdMl0OBnirMVyAcZ4rmFuvmHNWUuueDUuNg5jpRPnH9KmFwAOtc2l7g8VOL5TgGlYdzfWcE9akE4rDS6FSLdAtjNDKubgnBHQ1IJj2rGW5Hb+dPF0RUspam0spwDya29F0yTU7eeWOSOJIupkOK5GO7zgCu38P2Mmp+E9tvN5Fx52/JGQeCMGvPzHFPDUXOO+hvh6SnK0iQ+G9REIkjVJUYZDIc5FU7jSL63BMlrLkDPArqtKsNRsdMSJNS23HJOU+UH0FXlm1mKUv59vcoVwQRivBhn87+9Z/16Hd9ST2POpFaHPnI0Z7bhUZcEZzmuh+Idwxns0ZI1YplgtcaZ1BOBjnFfSYPEfWKaqHn1KfJKzLpYUmVX5uoqmJx3pwmB4rpvdGbRMSrseMU3IycDmoDJxxxVrTlWSVWfovP1NRUqRpx5maUaLry5Ik0FmzpvlG1T0FWUSJTiONc+tS3Fw0xDEYxxtFVy3mHYD8q8nA5rw8RipVHa+h9pgcspUIptK5KzqCQSM+lVpAWbGDWtp+g3F6PNB8uL/aHJq/JoKQKMSljWVPDVamiRtVzLD4d6s5ORHU8ErUE0rrgMA4z3robuy8snHP1rLu4EIAZQuR94UTw9Wlq9DahmGHxXup3PFvFltK+uznyHIbhcDitzSLR7TS4o5Ew57EV3k1kGkTCgkDgkZ5qtexLcxNGwUTJ0xXbg8w5JWn955GYZDCcJVKL17HJSbSzYxVNwN2c5FaFzEImIIPFZ8vTivpYNSV0fFShy+7Yr3AyD0xVCVRzV2ZuKpSHg0pERXQqSjHNV3IB3Z/OrEhyMVTcjJ3c+lYyNUNV2DZVtrZzkV9JfC3U2vvBsErSNJLG+yTeetfNIB3ZA4FfQHwQgkXwZNJcLtjll4J+lefiNVdnVh97Ho7XcAdU8yIM3QZ5NSLIpOPQ8nFUnitUeMtEhlAG1sHNXiFEZJyfUAd65rI6Tg5Fea2Jt4Vz37E1Bpxku0uY57V1EeAhyea0pVMrRiEFZF5PvUwnlGV2bGzjnjIqLsDKtrDdfeXPJbtCf+WbKMnisnxH8MdJ1OItpoNhdZJIU5UmupvNPtllFyYsTAZGDnNS2N35iHduGR/EOlQ73ugcUz588QeA9d0bzHltvtEA/wCWkRzXJNvj+VwVYHoeor6l1LNzCsSt/o8mRIM4/KvKPEnw3knZ7rRpvMBY5Q9a0hUf2jOVM8y3DIqVSMZq5eeGNfts7tLmIDEbgMjFY2+aLPmIRjrkY71qp3M+WxeDZbJp/uO9UI7xWOwgg9eBmrMdxHt4OSffGKtTI5SwCPxp4Zu3aqoYnDZ5xUsTHGcEGtFJicSdXbdk1KZAR8vWqe/saer4qlMTRcV29alSQ+tUg+BxT1etFImxeEpzzUqTYxjGfes7zcdelOWRSw9K0UibF+W7jhjaSdsLntU1teRytvt3ytZF1GtzAY3OB2pdKtvsSsN+4Mc0Rk0xWOgWZg2QpJ9ql81zhSu05zmsLUpZhZP9nkIk44FV9Av7idZFuWPydCaftNbBY61ZyO9SLOc5zWMs5PU08TnOAa0smK5urc471L9r4rCSbH1qVZ2PcUnDsLc3o7oEYbjNaVprN1bACC6kjx2ViAa5TzsgAN09alS4PIyBxwayqYeNT4lcqE5R2Z3kPi/Vkxi83EdAwzWhbePdQj5lSGVfQjbXnAuBuA3DdUi3LBm53Y7CuGplOGqPWC+43WJqr7R1+s63Jq999plRUbbgAdBWes3y8NmsRbtlZcnpT0vOoFddOgqUVCKskZTm5u8jb83d1NAlPrWMLr3p4vAAMnmtFFslysa5mznLdOlbmnfLax8cnk1x/wBq+UAYzXUWs22GMk9VBry8ybjTR9Jw/SVSrKT6F+aQqBs4Y9a474g+LzoMCWlngX0gyWPOK6iW4BlUkjn0rwT4gXsl34pvXZjtQhFz2xXmYWHtJ3fQ9zN6ssNQXLuzubX416/BbQxPFbOY/lZiMZFW4/jdd/aN91ZxNDjkITn8K8YaRwrBTnBqEsdgwPmr3VVcVZHw8nd3ep9KWnxO8Pajah7qd7WQ9VPNaula3pGsArp+oQS+qNgGvlMSMxPJzVmyvJrSVZ7eV4pBzuU4zT+sX0krjg3CSlB2Z9S3StBKV53AZB7YrMvAEuElX7v8QrhPhd4jv9Xu7i0v7lpgqb03dRXfNg4z1HWvAxMeWo+XRH6Jl2I+sUIzfU5/XIcOZP8Anp1rnpQA23sBXVa7j7ID74rk7kZY19DldV1KN30Ph8+oxoYpqO1rlS4YEEN0qnMOM9qnnK87utVHYgE9gK9FnjK63IZeVxVKQKuSTg9qtTuPzqnKyg9MisZNFoZjPIbk9q+g/gNvl8JTq84mCT48s/w8V89ptPJ6k4r6C+A8aJ4QllGEV5zk45OBXBW1R04d2bPTUjQnkAn1FJMsir+4Zdw/vdKWJw6/KR9cVXvtQtrQET5IPHSuazOg5O0iuIpsvKC4HRu9Pi+0Ncyb3dmJ3bSnyr7Zq4fs0zid4yRnggGppHWT5ICy715OOlaOEO47mW1reT62t2kkiwpHtKE8Z+lOWVLe9W2O+WSUZPHA/Grc7R6fYFpbhyw6gelNs5o3UtDG7sw4cr0pezhbcOZlGd4oYpAqEkZJGM0WtuqTQxr96UZxjpWodN3SI4ZsKpJ6cmnwYlSSbyyknbNS6UH1L5mjOubZkA2gMgzwR1PpWNLolteWipqOl2+STlAARgnrmuquGZAzKAWC8expIFaRVEmPMwMiodKC6jvc89v/AIWaFeQl44GgbsY2xgVyer/BqaIr/Zl9w3OHB/nXt8s6QI4ZSTnAC85qC4V8rMm5ScfKetCjGP2hNJ9D5n1fwJ4j0dnLQ+ei85jOeK595bm2bbcQuh9GWvru5hGxdjknGSCtZl7pNpqEa/a7GBl6Bwgya0513M3TufLUd7G4yeP5VOH3Y2YPfIr2fU/hVoEshZPOR5SSSpAx+Fc7qXwhkg3HTNRJ2jISRT/Oj2ke5DpHAI52A4OOlCkHvVzVPC2vaOz/AGi0aZBzvjBIrKF00cnlzx+W1aRnGWzM3TZb3c+1OzxgDioFlQ8bxViLlcA7lreLS6k8rHrJuwCuaeXAIxxiofung4oZuhrRTj3IcWWg3VgOf50vHVFCg8nFVo5OmelOdiDntV3i3e5PKWt5p6SEdOtUPOp6TVSce5LRopKc804TDdgnBrOM+D60plG4HaatOHcmxpGUE53VoaJazavq1pYQHDzSBd3oKwBJzztrQ0XVpNJ1S1vrc4kgkD8Hg/WlLla0ZcFrqfQN38ItFNo1taXzrqnl78F/vEe1eIXqy2d7cWs+RLFIUYDrxXt1l8UPCFwE1W6d4dTSPDLtOWOO1eC+INYOsa3qOpfcFxKWCngisKDlF2kzSqkifziE5O3/AHjij7QRzkMvqpyKXwtcWJ8R2I1WJpLRjtKerds1N40awt/ENxFpqeVGv34h0U//AKq6VOPcx5WRrdZp4uMgc81jx3FP84r8x6Gr9x63Fy21NgXB4wea621ujJZRuvTaBXniTlRnua6Pw/qIkhe2f7w5FedmlKEqfMnsfRcN4hU8TyT+0dHHIX+bJOK8Z8bQ/Z/Ed4snIfDrXrMUpXKHvXMeNNBXUUW6iGbhBhh6ivDwsoUpXb3Pqs6wssRh7xWqPLWUMMq2BUax7SGLHirs1rtkYbdjA4K+lQvbOVP7wZ9PWvW0a0Pz+cZKVrFVtu48gZpAoBwD8p4FSi2kxkhaWO1mlnWOJCzt0x9ah2WrCMZydkeg/BmEpqV9cdo4wnWvU3JHXOSOa47wRpv9jaeIdmZ5SHc+ntXVfaeQ33u2K8ut7OUrtn6JluFlh8NGnLczvEBK2Cg9c1ydy45Ga3fFl4ghSAH5jzXKvLwDnJxX0GVU4Qo+rPi+IZqeLa7L/MZI2QV9apykgMD6YqeSTgk8Gqcr5r0JcjR4TI5j0qtJg8HoakkeomGV461yz5CoiQxs06rGCSxwo7k19VeB9NbS/DNlZPGsbiMOwHqef618z6BJHHrli8w3osyfzr6stxGyq0ByXwRk+1cs4wZ20E7XJVM3nMAAE7HNEiPIm2Ros+4zRHNliHwXzzip18oNuKZYDvUctPua3fYxbqd5IytltCg88VHYyTR+dl0+UfjTpJIorbfLHtVhtAHBqjFaw2ryzNIzLIMYJ6VyKWhT3LjXUEyLHNbvIzHGQOnepIZE8xvmZAvAzwKltvM8sFdi5+6CKq/YZp7kSXsyvAv/ACyRRz+NQUzWU7lGA20ZHSoY5VaTyUiJVVzvPr6UlsShUxyMYj8x3HkVJ5zKrsUIHbHegQ2RVSE/Llm4z6VTG6BAM4I53Grd3dxwW6SNGd54wTxUEbpdHYyhiOSM0rAQtdEFTFGsqk/Mw7VcghjjJkVTufn5jmqFtaLBNcPbxSqrcjceM1bt1PmKHf5wMkDtTaXQq5ZZUBJKFlpjopASNP3fU89KtYIU88Y6GooWRc5znPSps+oNmfNbMZBMEURhcEGkkgWWB1gBzjIxzzWu0fmqy4zux2p6oqcFMH24oFc5N4r42UVutuDNI+Mt0xWdr/hnS5oc3+lJOx4zEoU/pXdSWySbS275TkHdTjGSCxIOPQUhHh2ofCyx1BAdPjlsWPI38iuQ134d+IdFYPbqLyI/xRDp+FfTjweauSML37UxbdVUhOfSj2koj5Yvc+Pp3urWQx3trKjDruQgU5JUbBRlz6Zr6s1XQrO/h23lrDLu9VGa4DXfhLo14ZGsme0lPPynIzVwxGtpIzlSXQ8SO7dnGc0Nk9Qa7LWvhZr2nB5bCRbqFRnrzXHXdtqNjJtvbWWNem4qetbqqnsZODQ0OM4p6sSTgVS+0ozckIc45qUTL8xDDHatIzsQ4XLStkc0obdxVdSzHAK+p5qwowhORkVtGd9yHG2gHH8PH1pC5Xt1pGwRnrUMkpyMg4q3NE2J/MyckA04MWOTVMykAnHFKs5I4pc47GjBOUmiPcSA1f8AGLk+IbpwPvBSf++RWHE5aaIA5O4DFa3i2VW1y5KtkAKv/jop8+grFSOQlKf5uUGTVCOTAwTT9+4Dt7U1PQLFzzjgYqzZ3kkEyyR/eFZhcleMUK7AZyKHyzXLLZlwlKnJThuj0KyvUvLcTKfnx8wz0q2rhiFZskDNedWl/LaPuiOB3X1ro7DXoJ+JsRSdM5rwcTg3TleKuj77K89o4iKhWdpFrVdDs78tI6FJP7y1z8/hObI+z3Ebr6MK6tbgEAqQQe4PWgy5YHarEfhXPGvVp6HbWyvCYp88uvZnIx+Epy+Z5olT0UE10GiaHbae2+Bd0uOXYcfhV/zsHODSCZmY/Nwe3SiWIqT0Y8NleFwsuaKu/MteeVyofJPU09LpYIDIx2qvcnrWXcXkNuhMsiBfTNc5qWrteHy4+IB39avD4WVZ26GeZ5pRwtN8rTkT6lqDXl3LMw4PQelUGlHXtVbzSSABwBjNM3EHA7DrX00EoQsfm1Wcqs3UnuSvMQeeaikkyKTf8ucdagdtxx0puehkl3F3c5PSmSnjKnkkYpNwIK9KZtJwM8DmsJSNIqxreH4Xk1S3URb1U7mI7Yr2Cz1u4tXjaB2Ke5ry7w2GsLF5dmZXb17V1MephURJDtdhwMUKncpTszuoPF06T7JTHt646E1op4sMlwkjoFixghTk15hJNKW3lV+vc1ctpmX5kb5D19jQ6SNFWPa3t/MwtynmY+6egFB09WJ8wKFJ7GrcqKzqweTPpT8AscE++a806LlK5hSHDIzbhxjHakWJYf4nIIzwKsqWabsIumSKZPdxW8UjnjbnHFCHcjNukhVl37WGSPSqN9feVbSySDbDENodh1IqbTbsXKLK5Lq68AcYpsunpeBo3iGzOcGjqMzbG6iv0ieNg6cllYflUjQqtwk0W4SfxIB1rXitrWNI0g8uNhxgd6teT5cihUZ89wKeojDm1gDVYrJ7aXzChZQo4P1q/Czu3mMiq+B0q48ao7SqpLqCu5l5GaZCh8tArdB3pgPkIaISzcKvOe1JE8Xl7hjnofWorln8ry/LLKDk4p9s7FMKjIB0yKmzAuRNnBxzT2IPJHXio4RO6M7YwP1qSFjLGTj5ulTZisKE2Lk/dpwUKQAoP0pIxIGCoAfUGpCjmMnGWp8oys+yRiDuGOOaryOsQb+4B8zelSy2ztHkoVO71pTFsGCmSwxzRZdRECFJJIiW+QjOe1MvCQiJHGSMnn1q1PsjeNV9McDpTfKkcjuAKhxvuU3ZFGSCUzKCP3LRjg9Qap3mkWN1CsVzbxzA53B16VuW9rcMq7E3FW/ip9x5EO1rqVY5CSAo71hOtThpzalKLfQ8n1H4UaFqayNFBNbPnhlPH5VwniT4Q3mnwyy2F2bjYRtQrgnNe4arfpK4S2MoUcHArn9MXUrO7uyT50NwQP3n8Fb023G5nZXsz55vfDOv6YjPdWE6xryXx8tUbZr1pVjjtZJWPZVr6h1JIJrN7bUbiHYB0Nc3dT6ZZOGtnVlTAAjj5rqjzGDavoePweF9ducD7AYlboZOM1FqHhrULAlb020bDt5nNegavr6LeJLFaXUuDkBuBXK67qz6teeY9jBFJ0GT2q7tasTSscZPKYeDhh0ypyKYLgE+lTX9lePI0kdo4RDzsUkD3NZzeZG+HTn0xTUkyXGxv+HgtxrlihI2mVd30zzTtclMutXrgfL5hA/CpvBSJHPd6xOuy30+PcAf45DwoH41gvdiSZpMnLktz7nNU3ZEl0yAinI4xnNU2nQYNPWVW5BxTT0K5S4pHehmUdDVUzcCl35Io5g5Sxu596GbK4OP61XVzznrSeZ8/NDlcFFmhDfT24HlTN16HmtA+ILxG5ZHGPSsAvycU5WyOetZSpU5bo6qeNxFJWjNm8fEF0Vzti/Kq0muXTj7yqD6VkFyDg9KR3xjjikqNJdC55jipqzmy3JOZjmVi1LuAAGcr6VU8zPA61JFJnr2raDjFWRwTcpu8ndlrf8ALxTWO0DByTUDP3HFIkocH2q+YhJkpYlsDpTJDxx1pgf5jk8Go5n2jK80c4JCSEj5h1FWNPj+2TrHgkHk47Uy0P2gqp5Hetm0tBbvviG0mhRbYOVkbMJSNFjhGSPlxU6IyyhpPmbtntWZGsiqWz8xOavW5lYfMMn1rq6GZo72Z9zDBX8jU8Um0bkQ8+vSqES3QbA2eWemTzV2NyRsJbI9KNGCPooRZzjj3qMxkNgNyec0omZEZcZx3qq0RMweV2I6BRXl8tPuejqTZCxOd3y9OOpNVGiD5CgFO+e9WASgYQmNsHOzPNNiimeMPNtSRj2PFHLT7hqQ20DRlvMxnOF2joKuQwlTnOD33Gq1zJLGkfK4JA6c1JtBcl97c5wKFGmUNkhl+0KixJ5DZy/dT7VatoJIYyjSvIeuTT/NVVXONvQDPIpXkbKR+WSnUuO1O1PuLUbLCT8xypNL5cgjHPJPBxUyyIfl3Bieg9KjSQPceWJF+TkilaACMuwNu5J4zUIjZ04zx3q2wVt6n1pSPLPyDCY5JppUwI4kLoBuORU6RMqZAwR6Ui5XGMY9amUMX+TOR29aVqYale3fesjuGG3qPWhYZJJPvkAdaV5f3jB8p65Ip3nAIrp84Y4O3tT5YBqI0LCdXSVsbeU7VGxcXClYxt/iNSwsHmby2JCnGOhqeViXGUxzSap3Cz3I/IJjUgDk5xin3KQadavd3HygDOPepoXAkQEgYPSuQ+LWoSiygtYCwE74OK8jH11zrDwdnL8jooxb1aOd1rxfq2r35stCyGJxlew9a7eTQmXTtPe5meW6gX94394ms7wVpEWnWalYP3zgZfHJroPEOqRactrbyMAZn8sZPfGawq0qGGqQhDru+rNVKUkzn7yxYf6ohe/ArHvLJ9v7yVif7orqJWLKcKc9KrvbgMHkUk9a+gjGktEcDlLqcvLosKW7S3XORkKax0sVvLwJFFhBzwtdZexTXsx3YRBwBSz7dOsWaPaJMYya1UabIab2PO/EtoLb5RtXPyquOSa828UqljOsRbEvUt716LqFz5N6JnQ3E0rY3P8AdX6V5t48tmTUX8zLcg5PfPpRL2VrISU7mjp15qOkWzajp5G5lxKjKGUj1wasQarb69cwQ32jWtxLK2A6fKT6jitvw9p1yuhRrqMLIkmERyOGBHSsSx099GnvbkqUmVzDBn0P8Qrhw1anUqOm+hvVUkkamq6HoV/ENG025exhhk3Nu5SR/Umsub4O6vNCZrKe1njJyChxmo7awupJdkZJ3egJNevfD/TbvT7ORp3lCsowj/0rrqezS0ZChfc8B1b4e69Ylg+nyHHQqCawLjS7y2P763liPoUI/nX2ennbFwFb681UudOhunb7RaxPj+8gNZKrFIHT7Hxi5lX73B9OlHmSgg9q+tL3wfoN4pW70+AseMhcGuZ1r4R6FJGz27yWxPTHIpqrEPZM+cRcSE9QPemSTSD5gOfX1r2K4+Ds8UDSxXqeWcnLr0HvXmeqaNcW128e0lUyNwHBx3p+1iONCpJcyWhkrdSF+lTLclm+7yKvWGgX15b+fb2s0kWSAyqSKe2g3sDhZbWdGIzyhqlKL6mLi0Z7TO3ak82QqBjgVPJZsrEEMMeopDbuvDZx6CrVhESStnBGD61NCQCSTnNRmE5wM/jUscOAex96tcpLbHEk4BANIiFJCcYUjpTkt2XJZwfpUmAFXJyM9aPcI1IJeY+BU1tB5owTU6ojNjP4etPSPY5xTXIDuWre2EMeY1UnvVqGQbwAME1Rj/1gO5gMdKtLNtyuPoa6IypkWZeMy4zJ8qjrilt5fNz9nLEe/aoYgkmAp+u6rESGKVTAuc8EVonBbk2LBMioDHJkj+GpIZ7lR5gjVk7881YtbUM4MilSD0Fa0VqshEcacN1xTvTHGLPdsrt2uxBPNUEuoby4McU7gxcPtFW5JA7uIJDx970pN0ccR2oFDdSB1rwj0RLWCCJi0eHLdWPWpnDBmIQMF96ZbeWRujwAOnvUsDTCdlaNRH1BFAyREDxCRiCc520yRdxYhuSDU3LNyVz7VEwJV1ckj270AijHp7vfQ3TXBGxSPL9c1oIrI7bHcg+tMjkG1f3IRF6MetTTAsiBX2A9h3oGQMT9o3QEEEck9jVi2jAUu4Xf6nvUcYCzbTyPWnyCRlO04I6UCHySxrMVdlGcdKcQJI/vfuqrRuwjCzjJz19KsxPu+ULx60DRHHv8lgmWOalZ3YhtzKw+UgUy5eaKLdGM/N1q0vzBW3YY9aAKEGmxQztLmSSV+zuSKmaXZIsMcIVjzkdKtybsYAy/rUbjYh4zmi4ETN5rCNTskA5YVYQSYAY7mXp71BkeXtA2e+Kjik8sNmYkfSlcfQuGTMqvt5WsvxlpR1fTFltxieNg61ZW4RZMH7o53GpRdokoZZQdwyUrx8zw85SjXp7xOihJfCyPw1O01pCHA3INr57EVw/xRtpdV8X6HZSyvb2oJfzF9elehQxwyuZ7UhJCDlPeqt/Y22qpANQi2XMLhkb3BryZZjF4inVqK1tzeNLRpHP6ZdtaXp0vUwRg4glz98e9bU8LKm0k+xqC+8Lx3TStLLJK78jnhTVa2tfEGm7I0RNRtxwPMOGUfWvo6OY4aS+NHHOjLsPuhHZxZnbc55ArktedrwYjDBTXdz6S17GGn/cM3UE5xVOXR9LslEl1cbtvXc2BU1s2w1PaV35ChhpyZ5Pq2jXV7eWdhYRvJcsckgcLXU2Pw1sIHS+8S3H2iSIZEWcLx61p6z4+0bRw0enKs078BYh3rhdVl8Z+MWENpbNFA7bcDjg9ya8upi8RitEuSHVnZGlCno9WbCeIx4q8dW+i6PBG2mwJ+9IXhQPSsq90mLWviFdafeS+Xb2q/IqdzXaeF9C034Z+HbiSeVJb+YFpZT97P90VF4H0OS7W61fVUPmXjkop7Dsa1y2rzVmov3Iq1+5nXS5UaemaBpulohjUEAYDMMmtZkU4UsGz0xUkNo6AhJg+D90jpSpHdBsbYsN6V7aRz6DEDhCqjpT22qPlJBPrTxFdKjAbAajEE7riYj/gNDdyWysyHeWdgcVUeFru6TgiMHmtRbVFP7wEgdM1OoXIOOR0pFKVjOv7JLi3e2bd5cilTivOtV+GsV1F5Iv2jgJ+cbBux6Zr1IhkOQnXNRGMYXdyajlTdzWliJ04uEXozB0bSbXSdOisbOMpaRLhWI5Y9zT5La2uWVyFdh8hUjrWxMMOQyjHbiq5h2uWjcLu46U+VJmfMc3e+GdJWGQ3VrAyyHsMEVhSfDjQ5kDeXIgbowc1299paXkQFxI6hemDjNPtIDDbLFI/yoMDPWq5rbByp7nmOofCfT3XMFzKuT1bmsp/hTIxxb3gwvqor2YwRyqMuQM+tPjtjGYzGN3PrTU5EuETwK8+GmqW5PlgOPasC58H6tbyYazkIB7CvqCSEu20jio2sE44H1q4131JdGPQ+VZdNnt3ZZY3U98jpUX2d8Z9a+m77w3Y3rulxbRsG6sBgisOX4f6PGC8ccgfPHPFbRrx6mMqL6HgBhI45zQSVdEwfcjtXuVx8PdPeTKuwyPTpVSX4caesbPNM4J6YrSNePQzdGR5FahBIVB35/St/TbcNII1Ri1ei2vw202BlcSu6kZxW7F4RsoQGizkEGtHiVaxUaHVnJ6X4YvLhEdk2Rt/Ea6y28JxW0alJcXAOQxGRXRWcOxcZ496neN1IKjPNcrqNs1jCKJTDgY2qqMMlhxVa2u4pt/2WZHSM7SMdKnuZ41cQAkN6HpiqllHZRROLdRhn+YL3NCg7bBdF5EEkbbcKDRbRGJfmk3EdMU8KYA2FIOOFPpUck7bVKrs+oqeWXYdwubyKziZpwHIxkAVymoeIb0asRp1mz23ACkc/WuqkjEuVdVYnk5oSH5gVVQMYJC80csuwEKh7qFGk4ZgCUz0qW7LW8QSIb2wME81JHbpbxluct6nmo2RQjkk5xT5JdikS28oZAGB3Dr9al3s0hIHtzVa2SFhkO+734zU/wAjs0cbneh+YdaOSXYVidYsK2cH2qaLYq4Y7fao4gI87jknkGgufNCmEvnvRyS7CbsI8rCRggBjPY1J8uOSFJpJNkbnPBPalVd33sZP44o5JdguSFh5eFY7h3FRonnYJYgDtQqyFty4wv61NDt2Z280vZvsFyOPJLZ3ADgA96a4G3GOe4qxKuRyeR7VCrfPkjg8UOEuwuYa0MbQIXUMD1qs8MXmqfKVWHCkelWJ90EIRQWZj09BTsGWVd67VUYB9ankl2Ki7kYhbzflZYyOQR3p0l20fE0Xmp3ZRzU5XAJGDUiL8uAvB715uKyqliL3Vmb08TKOjKAurJgAl2YG9H4pJYbmUZttUXB9ealuLG3uGIliVj7iqg0WzYYWJkOedrHivIlw7Uj/AA3/AF950rGRe5Rv9F1m5jdIdaEe4feCHiuWuPhm12S2teKLyZByVV9tdw3h62zjzrgKR2Y01PC+mqPm8+Q/7TnmtKeU4qnpB2HLEwfU5K10fwZ4bIbi4mToZG3kmrreJ9SvAtv4e0iVQ38brsWurttA0y3ctBZRA46sM/zrREKpGPLAUY6DiuqGTcz5q0m2YyxSWiRxFp4Rku7oXfiS4a6lX5lt04jQ/wBa17W+nTUDbC02WijCkDpXQqCFwSC3XBprbDlGAr16OHVKPJCJzTm5PmbK7AhGdNgXHTvVUK0iboQN46Zq0lvHHJuAY7uxqdkU4IGM9gK15H2I5jLsJo7qKV1YF4zhlx3qco2d7Hg9hU0aRQ7khRUB5PHJNKqCP5mJIPGKOR9hcwxVAxkZz60yRFMmFyKssAwA7A5zTAd8rZG0rR7N9g5iIpkgKwG0Z+YVHLggHYAKmuJjHtQ4LueuKZI5A4Iz0A9aOR9geu5XZWLFiD04qGVMkKRlSOamCSE/McEnpVS9ungZI44i7OwGQOgpqm+w00iQxgHKIMdcGqjI0xGPxBq95coZWzwR0oywOQBgfrR7N9h85ntbIELNGSF9TUkYjWPeqNhegzVkB5Mkrt559KdH2Ax7ij2cuwcyGRl5EG6PYfel59DgdBTHZpQVwyr1DE0snneQvkOGb+lHspdhDyMp85I3DkVVeJnRR1Gamy0YC3Eykv0pzKy4UAkdsU1SfYLortboBs4HPHNQSRYkDMmQvryDV9lYxlQF3Hue1Miil8pleVSO2Aafs5dguiEmQjdGqBe/FNaRchdx5qYQbVwWJzSeXIJlQKpGOtHspdguVyrNja461cwHiIyRt702ayLLjJBznIqRF+UgN045HWhUn2C6K7zB3LHbGh6Fh1pqQYw0YUDOTxTFlQLI8/IX7qkcVaidtuCC27mq9rIOVDS/lOXbc7tx7Cq2o65DZGPerSseNqrmrUcrmLMiCNx69xUW5TcqAqkkdcUvaSC3YtLKJFDiMq7jkelEDsMBOvSoYt4JLvlegINTDcZt0W0DpjFHtZBYbO+ZAE+Zx+VK5LZwgPHahFbJG0Ag8kdTTzFu6HaaPayGkihPFM3zKu0gjHNOS4Cb4REVlbJeQcVakZ/K8tQpcnAOOlOe0dgqzDgjDEUe0kGhWM2y1UqrSyDoQepq9Fcu0Slk2seoB9qjtbULC0anKqflp3lMOo59RR7SQuVMiKlpVZZG2jqDUwmdUIjiJJOOOtJtPksAAuOpNR2g2SM8jtnHy4PFHtZByouQr0O1kPfJpQVAZkRgAe5qFHkuZiSR5OMZqy2FIzhl7jNHtJBYmZwcBuSwz+FQySgOEU9Kc8qKysqDJ/LFUruCV1Mlk6iTOfmo55BYvl1QKCS2afnPyoMg9TVazk8xUZm3SYwQOlWU3feUjjhvrU88gsnuLjA2sOBQkuwnnjtQHZUZSV2nuagmVSw5yBzx3o53fUfKuhOJAGLEU9GViTuxntXO+Idcj0uBHeKSWZj+7gTO5z+FaWmXL3Nuk00RhcjJQjG32pc8lswS7l+M4JBfJFTBv9oVVYqzBRkE87v6UpwkbEfM/YU+eQWRYJPQd6azsnGAcVG0pGwIDn6VHJJIZMNgk9DjFLnn3DlROzM8y/KoGKZLKoGdhz6imt8i/vSGz6U12Kp+7bA9DRzPuFhyXICqpzke1NW6HC5OTVZ2Zs7yM9sHrTY/vEh1Vh29arnl3FyommuAku52URjjJ9al+0/Ltxk9az763RrPLOpBcMc84qxGxlXeq4JOKPaSDlSJmlL4dhtApPMk3KwX/wDVVdTMzyROvyqetWmLbht547dqPaS7hYaSN53xlgehqJt4K7EHHrVlDiMhjSSZ8sbcc/nT55dwsVkaThpApzRL8jAtjjoBUJKrc+WGxkcgn+VPz5ScKWOckk5wKPaSFYdGXE2QuQajlQjnqPepQwDDEnLc0rxlh8xyB2o9pLuNIh3ZXgYUVWliJO9TgVeI+QY4GelVp3CqQpXd2GKXPLuFiNztWPE2SeACOlTxOY0dZAC3qBTId+V3BWB657U6aBXcEysrAYHPFX7SXcVjP1CwW6QGQvuH3dvarEENxBGiqC2P7xq1FHJFEGDhyT1pT5hTcPmHc0vayCxUvftUgDW6KGHVT3p6yyFAzALIOoHSrnlsVYhOCoxVd0Y5G0KoHNHtZAkNkKFN38fc0xDH5gbOSO9DYddgHHTNAijVccgjsKftJdytCVpSWOCTj0qGTdvyueR0p/mDyh5aYPfFLkFRtJ3A9+an2k+5NiirebkOARn0q5GxYqDjr2oorMGNu4VafLZ5X196RIURMqOelFFSxrYcI1j/AHa/d3GpoQFWRQOAM0UUIGBQDMvO8YpspzKuaKKokmUBrhUIG3FEA6gkkZPWiigoANko28bhzT2JUjFFFBQ25QTJsf7pHamrEqLHGB8u2iigBLeJVIUZ2lqlWBBI+C350UUCK8ozjJPB9aI5WC7BjaTiiiq6AXExEI1jAAI5qfYEKhejDJooqQK18vIXJwaeFCR8dlyM0UUDQ0EeSXKIz43AkZIPtRGd2wEDB5OKKKUQGrIzXhgJ/dhSwHuKXzGRXYHkUUVTAktc/ZQ+5i2fWomkaUNvOcHFFFAFny1+z9+aa0ajaOaKKlgR3X7sEpxiqq84kPLHIOfpRRTQC2qK8UoYZHXmpJXZJIVXgHmiigTLbnagYdSeagicm5k54HaiigCWTmq10SJIxk4ooqhEssSMPMZQXToaauGTJA5FFFA0Qy4VNwAyKczsVUk9aKKQhsshjQlcfjURAkVXYDdRRTGKihFbb605TmbBwRRRTAswqGj2kcZPSmsPKiwnQ0UULcTGl2CgBjULEkYJJBoooYEiAKuAKifl80UUDI7tzFBEUwCx5/Okmby0BUDOM80UUwP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    If you have severe altitude sickness and cannot get to a lower altitude, you might be put inside a special inflatable bag called a \"portable hyperbaric chamber.\" This bag zips shut and can be filled up with air that is similar to the air at lower altitudes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Charles Marquette, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24880=[""].join("\n");
var outline_f24_19_24880=null;
var title_f24_19_24881="Pneumatic dilation fluoroscopy - balloon inflation";
var content_f24_19_24881=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66408&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66408&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumatic dilation for the treatment of achalasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 302px; height: 559px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Arrows indicate the \"waist\" of the balloon as it is being insufflated with air and pre-injected with water-soluble contrast.",
"    <br>",
"     (B) Obliteration of the waist with the balloon fully inflated.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Courtesy of Linda Nguyen, MD.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24881=[""].join("\n");
var outline_f24_19_24881=null;
var title_f24_19_24882="Eval metatarsus adductus";
var content_f24_19_24882=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60426&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 504px\">",
"   <div class=\"ttl\">",
"    Evaluation of metatarsus adductus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 484px; height: 575px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flexibility is determined by whether adduction can be corrected with manipulation back to the normal position.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24882=[""].join("\n");
var outline_f24_19_24882=null;
var title_f24_19_24883="Dense deposit disease EM";
var content_f24_19_24883=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F73319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F73319&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electron microscopy in dense deposit disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph in dense deposit disease (DDD) showing dense, ribbon-like appearance of subendothelial and intramembranous material (arrow) and narrowing of the capillary lumen due to proliferation of cells (double arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24883=[""].join("\n");
var outline_f24_19_24883=null;
var title_f24_19_24884="Azacitidine: Patient drug information";
var content_f24_19_24884=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Azacitidine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/40/12935?source=see_link\">",
"     see \"Azacitidine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F138149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Vidaza&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14476760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Vidaza&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021251\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692094",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat some types of leukemias and bone marrow problems.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701574",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to azacitidine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver tumors.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697767",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use 2 kinds of birth control that you can trust 1 month before care begins, during care, and for at least 1 month after care ends.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy. Use 2 kinds of birth control that you can trust 1 month before care begins, during care, and for at least 1 month after care ends.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698275",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. You may need drugs to lower this side effect. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698081",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698360",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling in the arms or legs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into the fatty part of the skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11296 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-24A2ECD58B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24884=[""].join("\n");
var outline_f24_19_24884=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138149\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14476760\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021249\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021251\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021250\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021255\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021256\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021258\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021253\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021260\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/40/12935?source=related_link\">",
"      Azacitidine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_19_24885="Telaprevir: Patient drug information";
var content_f24_19_24885=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Telaprevir: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/6/20585?source=see_link\">",
"     see \"Telaprevir: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12851805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Incivek&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F13374970\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Incivek&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F12861989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4084822",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug can cause bad skin side effects when taken with peginterferon alfa and ribavirin. Talk to your doctor about any skin changes you may have.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F12862018\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691882",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat hepatitis C infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F12990505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3452124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to telaprevir or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3449030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are",
"       <b>",
"        not",
"       </b>",
"       taking ribavirin or peginterferon alfa.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701069",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are of childbearing age, but are not using 2 kinds of birth control or if you are planning to get pregnant during your care or within 6 months after care has ended.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man with a sex partner who is pregnant or plans on getting pregnant at any time while you are being treated or within 6 months after your care has ended.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F12990509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697168",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have anemia, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2956564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gout, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697263",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have hepatitis B or HIV disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697234",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an organ transplant, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having surgery, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort with this drug. This drug may not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697774",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use 2 kinds of birth control that you can trust while using this drug and for 6 months after stopping this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697016",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man and have sex, protect your partner from pregnancy during care and for 6 months after care ends. Use birth control that you can trust.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696918",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use a hormone-related kind of birth control.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F12862021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698074",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697879",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696431",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals and good mouth care may help. Older children may suck hard, sugar-free candy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F12990506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699056",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shortness of breath.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark, tarry-black stool.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698972",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth sores.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F12862020\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695900",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a high-fat meal.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F12990508\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose, brand, or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F12862022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699601",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throw away any part not used after 1 month.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F12990507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16496 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-210.101.131.232-F6895ED81D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24885=[""].join("\n");
var outline_f24_19_24885=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12851805\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13374970\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12861989\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12862018\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12990505\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12990509\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12862021\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12990506\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12862020\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12990508\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12862022\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12990507\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?20/6/20585?source=related_link\">",
"      Telaprevir: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_19_24886="Myelofibrosis marrow collagen";
var content_f24_19_24886=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69139&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bone marrow biopsy in primary myelofibrosis stained for collagen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone marrow biopsy from a patient with&nbsp;primary myelofibrosis stained for collagen (trichrome stain). The marrow cavity (arrows) is traversed by blue-staining collagen bands.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen A Landaw, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24886=[""].join("\n");
var outline_f24_19_24886=null;
var title_f24_19_24887="Localization VFD";
var content_f24_19_24887=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F74068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F74068&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Anatomy of the visual pathways and visual field correlation (view of underside of brain)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 457px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Liu, GT, Volpe, NJ, Galetta, SL. Visual loss: Overview, visual field testing and topical diagnosis. In: Neuro-ophthalmology. Diagnosis and Management, Liu, GT, Volpe, NJ, Galetta, SL (Eds), WB Saunders, Philadelphia 2001. p.55. Copyright &copy;2001 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24887=[""].join("\n");
var outline_f24_19_24887=null;
var title_f24_19_24888="Maintenance of sinus rhythm after cardioversion in atrial flutter";
var content_f24_19_24888=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Maintenance of sinus rhythm after cardioversion in atrial flutter",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24888/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24888/contributors\">",
"     Jie Cheng, MD, PhD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24888/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24888/contributors\">",
"     Bradley P Knight, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24888/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24888/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/19/24888/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of maintaining sinus rhythm in atrial flutter include prevention of hemodynamic compromise when there is a rapid ventricular response and avoidance of symptoms due to the arrhythmia. Prophylactic antiarrhythmic drug therapy to prevent recurrent atrial flutter is therefore desirable if it is effective and if both the toxicity and proarrhythmic effects of the drugs are low.",
"   </p>",
"   <p>",
"    The recommended guidelines for the maintenance of sinus rhythm in atrial flutter have been similar to those for atrial fibrillation (AF), since many patients with atrial flutter also have periods of AF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20938?source=see_link\">",
"     \"Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, these arrhythmias appear to have different pathogenetic mechanisms. Atrial flutter is increasingly being considered an event involving the right atrium with the left following passively; in contrast, AF may be primarily a left atrial event in most patients.",
"   </p>",
"   <p>",
"    The rate of recurrence of atrial flutter is somewhat difficult to determine because most published data combine atrial flutter with AF. The recurrence rate, however, is substantial. This was illustrated in a study of 50 patients who were followed for a mean of 3.5 years after cardioversion, and without the use of prophylactic antiarrhythmic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/1\">",
"     1",
"    </a>",
"    ]. Sinus rhythm was maintained at six months and five years in 53 and 42 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/1\">",
"     1",
"    </a>",
"    ]. Using a protocol of repeated cardioversion (median of two per patient), sinus rhythm at five years was maintained in 45 patients, although 16 patients required chronic antiarrhythmic drug therapy.",
"   </p>",
"   <p>",
"    Thus, recurrence is sufficiently common to seek other approaches to the treatment of atrial flutter. A change in the paradigm of therapy is occurring in recurrent atrial flutter from traditional pharmacologic therapy to radiofrequency (RF) ablation. Type I atrial flutter, which is the most common type, is particularly amenable to RF ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommendations for the maintenance of sinus rhythm in atrial flutter largely overlap with those for AF, since atrial flutter may be a bridge between sinus rhythm and AF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/24/12682?source=see_link\">",
"     \"Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Clinical trials\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20938?source=see_link\">",
"     \"Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/European",
"    </span>",
"    Society of Cardiology",
"    <span class=\"nowrap\">",
"     (ACC/AHA/ESC)",
"    </span>",
"    guidelines on atrial fibrillation included recommendations for electrical and pharmacologic cardioversion and for maintenance of sinus rhythm (",
"    <a class=\"graphic graphic_table graphicRef72962 graphicRef58616 graphicRef65532 \" href=\"UTD.htm?20/1/20510\">",
"     table 1A-C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef78424 \" href=\"UTD.htm?25/39/26236\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef83173 \" href=\"UTD.htm?35/57/36766\">",
"     algorithm 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    DC shock, overdrive atrial pacing, and antiarrhythmic drugs can be effective in converting atrial flutter to a sinus mechanism in virtually all patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18201?source=see_link\">",
"     \"Restoration of sinus rhythm in atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As is true for AF, the maintenance of sinus rhythm in atrial flutter is often problematic with pharmacologic therapy. The success rate at one year has been estimated at only 20 to 30 percent, with the risk of recurrence being highest in the patient with an enlarged right atrium who is in heart failure. On the other hand, good prognostic signs for maintaining sinus rhythm are normal atrial size, recent onset, little or no heart failure, and an underlying reversible disorder such as hyperthyroidism, myocardial infarction, or pulmonary embolism.",
"   </p>",
"   <p>",
"    Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/2/6183?source=see_link\">",
"     dofetilide",
"    </a>",
"    , a class III antiarrhythmic drug available for use in the United States, may be more effective than other agents for maintaining sinus rhythm. It is more effective for preventing recurrent atrial flutter than AF. As an example, in the SAFIRE-D trial, which included 48 patients with atrial flutter, the probability of maintaining sinus rhythm at one year with dofetilide at a dose of 125, 250, or 500 &micro;g BID was 0.49, 0.38, and 0.8 versus 0.59 for placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/3\">",
"     3",
"    </a>",
"    ]. In contrast, the probability of sinus rhythm in patients with AF was 0.36, 0.38, and 0.53 versus 0.15 for placebo.",
"   </p>",
"   <p>",
"    The drugs that are most likely to maintain sinus rhythm are the same as those used for rhythm control in AF (",
"    <a class=\"graphic graphic_table graphicRef78424 \" href=\"UTD.htm?25/39/26236\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef83173 \" href=\"UTD.htm?35/57/36766\">",
"     algorithm 1",
"    </a>",
"    ). They act by suppressing triggering beats and arrhythmias and affecting atrial electrophysiologic properties. The choice of drugs is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20938?source=see_link\">",
"     \"Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RF ABLATION IN TYPE I ATRIAL FLUTTER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of type I atrial flutter makes its susceptible to effective therapy with radiofrequency (RF) ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type I (also called isthmus-dependent) atrial flutter utilizes a large macroreentrant pathway in the right atrium, with the left atrium following passively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/53/15192?source=see_link\">",
"     \"Electrocardiographic and electrophysiologic features of type I atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The negative deflection of the flutter (F) wave in lead II coincides in time with the impulse activating the low right atrial septum between the inferior vena cava and the tricuspid valve. Activation then travels anteriorly through the region of the low septum, and superiorly and anteriorly up the medial surface of the right atrium, returning through the trabeculated right atrium anterior to the crista terminalis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/4-8\">",
"     4-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cavotricuspid isthmus between the inferior vena cava and the tricuspid annulus (IVC-TA isthmus) is an obligatory route for type I flutter, and, as such, is a reasonable anatomic target for ablation (",
"    <a class=\"graphic graphic_waveform graphicRef69946 graphicRef60090 \" href=\"UTD.htm?8/2/8234\">",
"     waveform 1A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/5-17\">",
"     5-17",
"    </a>",
"    ]. Another isthmus is present between the tricuspid valve annulus and the coronary sinus ostium (CS-TA isthmus) which is smaller than the IVC-TA isthmus.",
"   </p>",
"   <p>",
"    Intracardiac echocardiography (ICE) has been used in conjunction with electrophysiologic studies to assess the role of right atrial endocardial structures as barriers to conduction during type I atrial flutter [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/12\">",
"     12",
"    </a>",
"    ]. ICE identifies structures not normally visible with fluoroscopy including the crista terminalis, eustachian ridge, the annulus of the tricuspid valve, the interatrial septum, the fossa ovalis, and the ostium of the coronary sinus. The crista terminalis and the eustachian ridge serve as lines of block during type I atrial flutter. Electrical activation maps indicate that the trabeculated right atrium anterior to the crista terminalis is activated and that activation is then directed into the narrow isthmus between the eustachian ridge and the tricuspid annulus (",
"    <a class=\"graphic graphic_figure graphicRef52904 \" href=\"UTD.htm?27/10/27811\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Technique of ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catheters are inserted to record the activation of the isthmus. Although DC shock and cryoablation have been used with success, RF ablation is currently the method of choice. A right femoral approach is generally used, and under fluoroscopic guidance, the catheter is placed at the IVC-TA isthmus where a large ventricular and small atrial electrogram are recorded. Radiofrequency energy is applied, and the catheter is slowly withdrawn towards the IVC. Often multiple \"burn\" lines are required to terminate atrial flutter. The use of a noncontact mapping system improves the ability to accurately localize the line of block in the isthmus region [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pacing protocols are used to determine or confirm the exact reentrant circuit of atrial flutter or to reinduce the tachycardia in patients with paroxysmal atrial flutter, and to assess the presence or absence of conduction through the IVC-TA isthmus. An infusion of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    during pacing may help to assess the completeness of isthmus ablation and the potential for reversal of block [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19866?source=see_link\">",
"     \"Catheter ablation of cardiac arrhythmias: Overview and technical aspects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The best marker for long-term success is complete IVC-TA isthmus block (",
"    <a class=\"graphic graphic_waveform graphicRef69946 graphicRef60090 \" href=\"UTD.htm?8/2/8234\">",
"     waveform 1A-B",
"    </a>",
"    ). This should be assessed with multiple-point low right atrial mapping to differentiate complete from incomplete block since incomplete or intermittent block can occur before achieving complete block [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report evaluated two different ablation techniques for eliminating the flutter circuit in 60 patients with atrial flutter: electrophysiologically guided focal ablation versus two linear lesions in or around the IVC-TA isthmus in 30 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/22\">",
"     22",
"    </a>",
"    ]. Successful elimination of the flutter circuit was equivalent with both techniques (96 percent) as was the recurrence rate (7 percent) and incidence of a new atrial tachyarrhythmia (7 percent) at three months. However, both the procedure time (104 versus 181 minutes) and radiation time (22 versus 42 minutes) were lower with linear ablation.",
"   </p>",
"   <p>",
"    There has also been some success in ablating conduction at the CS-TA isthmus [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. A concern is that a critical line of block may not be consistently found between the coronary sinus ostium and the IVC during tachycardia, a condition necessary for CS-TA ablation to be effective.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Role of intracardiac echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ablation guided by ICE is being used in hopes of developing a more effective procedure. One study using ICE showed that the best site for ablation may be between the tricuspid annulus and the eustachian ridge, rather than the more commonly used area between the tricuspid annulus and the orifice of the inferior vena cava [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/12\">",
"     12",
"    </a>",
"    ]. However, in most cases, intracardiac echocardiography is not of significant benefit in ablation for type I atrial flutter because the eustachian ridge can be readily identified without ICE during ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Electroanatomic mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;A novel method for identifying the appropriate target area for ablation is nonfluoroscopic electromagnetic mapping, which consists of an external, ultra-low emitter of a magnetic field, a set of two catheters with miniature magnetic field sensors, and a processing computer. This system permits precise reconstruction of the anatomical arrangement of the inferior isthmus.",
"   </p>",
"   <p>",
"    A study of 50 patients with atrial flutter compared isthmus ablation using conventional fluoroscopy for catheter positioning to positioning with electromagnetic mapping [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/25\">",
"     25",
"    </a>",
"    ]. The success rate for complete isthmus blockade after 20 RF pulses or 25 minutes of fluoroscopy time was greater with electromagnetic mapping (96 versus 67 percent). Electromagnetic mapping significantly reduced the overall fluoroscopic time (4 versus 22 minutes) and the fluoroscopic time needed for isthmus mapping (0.2 versus 17.7 minutes).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial success rate for the ablation of atrial flutter has ranged from 65 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In the NASPE Prospective Catheter Ablation Registry, 477 patients underwent ablation of the IVC-TA isthmus; acute success was achieved in 86 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/26\">",
"     26",
"    </a>",
"    ]. However, in most centers, the success rate exceeds 95 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Atrial stunning after ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial stunning, similar to that observed after reversion of chronic AF, may be seen after electrical reversion or RF ablation of chronic atrial flutter [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/40/37511?source=see_link&amp;anchor=H4#H4\">",
"     \"Embolic risk and the role of anticoagulation in atrial flutter\", section on 'Atrial stunning'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The likelihood of developing atrial stunning and its duration were assessed in a review of 15 patients with chronic atrial flutter (mean duration 17 months) and seven with paroxysmal atrial flutter who underwent RF ablation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/28\">",
"     28",
"    </a>",
"    ]. Significant left atrial stunning and spontaneous echo contrast on transesophageal echocardiography were observed after ablation in 80 percent of those with chronic flutter but in none with paroxysmal atrial flutter, suggesting that atrial stunning is related to the duration of the arrhythmia and not the mode of reversion. These changes resolved after three weeks of sinus rhythm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Recurrent flutter or AF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Between 7 and 44 percent of patients who undergo flutter ablation have recurrent atrial arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]; the recurrence rate in the NASPE registry was 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/26\">",
"     26",
"    </a>",
"    ]. The recurrent arrhythmia is often atypical atrial flutter or AF. However, the rate of the former is low and occurred in only 4 percent patients after a mean follow-up of 15 months in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of recurrent AF appears to depend upon the presence or absence of AF before the procedure. In a study of 100 patients, 29 of whom had documented AF before the procedure, AF occurred in 36.4 percent of those with complete follow-up after a mean of almost 15 months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/30\">",
"     30",
"    </a>",
"    ]. However, in another study of approximately 100 patients without pre-existent AF, new onset AF developed in only 12.9 percent during a mean follow-up of 19 months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/31\">",
"     31",
"    </a>",
"    ]. AF developed within six months in 92.3 percent of these patients who had new onset AF during follow-up period. The risk may be as low as 10 percent (mean follow-up of 20 months) in those with no prior AF and a left ventricular ejection fraction &gt;50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study of 363 patients who underwent cavotricuspid isthmus ablation for typical atrial flutter, 82 percent developed drug refractory atrial fibrillation during a follow-up period of 39",
"    <span class=\"nowrap\">",
"     (+/-",
"    </span>",
"    11) months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/33\">",
"     33",
"    </a>",
"    ]. Elimination of atrial flutter may delay, but does not prevent atrial fibrillation and the two may share common triggers. Therefore, patients may derive a better long-term benefit from additional anatomical ablative treatment",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pharmacological therapy of atrial fibrillation.",
"   </p>",
"   <p>",
"    Anticoagulation for the prevention of embolic events may therefore be necessary, at least on a temporary basis, after flutter ablation due to the development of AF or recurrent atrial flutter within six months. However, there are no data available addressing this issue.",
"   </p>",
"   <p>",
"    In patients with no history of atrial fibrillation, we suggest anticoagulation for at least one month after ablation for atrial flutter if the patient presented in atrial flutter. For patients who present in sinus rhythm and have no history of atrial fibrillation, we do not treat with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    after the procedure. Patients with a history of atrial fibrillation may require longer term anticoagulation with warfarin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link&amp;anchor=H46#H46\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\", section on 'Periprocedural embolic events and anticoagulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Improvement in left ventricular function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent atrial flutter can result in a tachycardia-mediate cardiomyopathy, similar to what has been seen with AF and other arrhythmias. On the other hand, reversal of the arrhythmia can result in improvement in left ventricular ejection fraction and, in 6 of 11 patients in one report, restoration of normal function [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/28/6601?source=see_link\">",
"     \"Hemodynamic consequences of atrial fibrillation and cardioversion to sinus rhythm\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency ablation improves the quality of life and reduces symptoms in patients with atrial flutter, particularly if there is no associated AF [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/27,35\">",
"     27,35",
"    </a>",
"    ]. Other benefits include a reduced frequency of hospitalizations, emergency department visits, need for cardioversion, and the need for antiarrhythmic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Ablation versus pharmacologic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the high success rate of RF ablation for treating type I atrial flutter and low complication rate, pharmacologic therapy is increasingly being replaced by ablation as the standard initial therapy in many patients, except in the settings of reversible triggers such as pneumonia, hyperthyroidism, and other acute medical problems.",
"   </p>",
"   <p>",
"    The improved outcomes with ablation were illustrated in a randomized trial of 61 patients with at least two episodes of symptomatic atrial flutter within a four month period [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/37\">",
"     37",
"    </a>",
"    ]. The patients were assigned to conventional antiarrhythmic drug therapy or catheter ablation as a first line treatment. After a mean follow-up of 21 months, the following significant benefits were noted in the patients undergoing ablation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      More were in sinus rhythm (80 versus 36 percent with drugs)",
"     </li>",
"     <li>",
"      Fewer required rehospitalization (22 versus 63 percent)",
"     </li>",
"     <li>",
"      Fewer developed AF (29 versus 53 percent)",
"     </li>",
"     <li>",
"      Sense of well being and function during daily life activities improved with ablation but did not change with drugs",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Ablation in patients with implantable devices",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of an electrode from a permanent pacemaker or implantable cardioverter-defibrillator may make ablation more complex because of difficulties in manipulating the catheter and placing lesions in the appropriate areas. While RF ablation has the potential to alter pacemaker function, such events appear rare. Preliminary data from a report of patients with atrial flutter or tachycardia and implanted devices undergoing ablation reported that lesions placed close to the electrodes did not alter device function in any of 14 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pulmonary vein isolation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catheter-based therapy for atrial fibrillation (AF), as opposed to atrial flutter, typically involves total electrical isolation of the pulmonary veins. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many patients have episodes of both atrial flutter and AF. In such patients, pulmonary vein isolation (PVI), although it does not interrupt the reentrant flutter circuit, may be sufficient to control both arrhythmias. This was demonstrated in a study of 108 patients with both AF and typical atrial flutter who were randomly assigned to either a dual ablative procedure (PVI and IVC-TA isthmus ablation, 49 patients) or PVI alone (59 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/39\">",
"     39",
"    </a>",
"    ]. After ablation, the following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During the first eight weeks postprocedure, none of the dual procedure patients, but 32 treated with PVI alone, developed atrial flutter and required cardioversion",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      antiarrhythmic drugs.",
"     </li>",
"     <li>",
"      After eight weeks, all antiarrhythmic drugs were discontinued. Only three patients treated with PVI alone had further recurrences of atrial flutter, which was successfully treated with IVC-TA ablation. Seven of the dual procedure patients and six of those treated with PVI alone developed recurrent AF. Of these thirteen patients (12 percent of the total group), 10 underwent successful repeat PVI and three remained in sinus rhythm on antiarrhythmic drugs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings suggest that pulmonary vein triggers appear to initiate atrial flutter as well as AF. This conclusion is consistent with evidence that atrial flutter commonly starts after a transitional rhythm of variable duration, usually AF [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/53/15192?source=see_link\">",
"     \"Electrocardiographic and electrophysiologic features of type I atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Left atrial flutter after PVI",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to patients with both AF and typical right atrial flutter, some patients develop atypical (type II) left atrial flutter after PVI for AF. These arrhythmias may be due to circuits created by scar from LA ablations, but are often amenable to ablation themselves. This issue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link&amp;anchor=H26#H26\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\", section on 'Left atrial flutter'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Prior cardiac surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial flutter can occur after cardiac surgery, both as a postoperative complication and as a late arrhythmia. The atrial flutter in these patients is reentrant and may involve atypical isthmuses between natural barriers, atrial incisions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28602?source=see_link&amp;anchor=H2#H2\">",
"     \"Atrial fibrillation and flutter after cardiac surgery\", section on 'Pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of late atrial flutter, most often type I but also type II, appears to be greatest after radiofrequency ablation-based pulmonary vein isolation for atrial fibrillation. The frequency with which this occurs was evaluated in a review of 1345 patients who underwent pulmonary vein isolation for AF, 63 of whom had had prior cardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/42\">",
"     42",
"    </a>",
"    ]. The rate of atrial flutter was much higher in the latter group (33 versus 4 percent without prior cardiac surgery). RF ablation in the prior cardiac surgery group had an 86 percent acute success rate and an 11 percent rate of recurrence at a mean of one year.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     RF ABLATION IN TYPE II ATRIAL FLUTTER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type II or atypical atrial flutter may result from a reentrant circuit in the left atrium (as opposed to right atrium in type I flutter). Atypical atrial flutter is most commonly seen in patients with underlying structural heart disease, and also in patients with prior cardiac surgery or ablation procedures, as noted above. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/56/12165?source=see_link\">",
"     \"Electrocardiographic and electrophysiologic features of type II atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of 22 patients in one study who had type II flutter, complete conventional and three dimensional maps were obtained in 17; 15 patients had a macroreentrant circuit with one to three loops rotating around the mitral annulus, the pulmonary veins, and a zone of block or silent area and two patients had a small reentry circuit with a zone of markedly slow conduction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/43\">",
"     43",
"    </a>",
"    ]. Radiofrequency ablation, performed across the most accessible part of the circuit, restored sinus rhythm acutely in 91 percent of patients; after a 15 month follow-up, 73 percent were free of recurrent atrial flutter.",
"   </p>",
"   <p>",
"    A later study described 11 patients with a macroreentrant left septal atrial flutter characterized by a critical isthmus between the pulmonary veins posteriorly",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mitral annulus anteriorly and the septum primum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/44\">",
"     44",
"    </a>",
"    ]. At a mean follow-up of 13 months, nine of the patients were free from recurrent flutter.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type I atrial flutter is associated with a consistently identifiable critical isthmus between the inferior vena cava and the tricuspid annulus and recurrence is common after cardioversion. The main exception occurs in patients with an apparent reversible cause (such as hyperthyroidism or a pulmonary embolus) who may not have further spontaneous episodes. In patients who do not have one of these apparently reversible causes, catheter ablation may be considered as the first line therapy because of its high efficacy and low incidence of significant complications. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Ablation versus pharmacologic therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Either a rate control strategy or rhythm control with antiarrhythmic therapy is an alternative, particularly for the patient who does not wish to undergo ablation or for the infrequent patient in whom atrial flutter recurs despite multiple ablation attempts. The drugs used for rhythm control are similar to those recommended in AF and vary with the clinical setting . Rate control is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18328?source=see_link\">",
"     \"Control of ventricular rate in atrial flutter\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who have AF in addition to atrial flutter often undergo ablation for the atrial flutter and are then treated initially with a rate control regimen for AF. Although total pulmonary vein isolation can prevent both AF and flutter recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/39\">",
"     39",
"    </a>",
"    ], this is a much more complicated procedure than ablation for type I flutter. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5817?source=see_link\">",
"     \"Rhythm control versus rate control in atrial fibrillation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=see_link\">",
"     \"Radiofrequency catheter ablation to prevent recurrent atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data are more limited in type 2 or atypical atrial flutter. Although RF ablation may be successful in highly experienced laboratories [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24888/abstract/43,44\">",
"     43,44",
"    </a>",
"    ], many patients are initially managed medically with a rate control regimen, or, if symptoms persist, cardioversion followed by maintenance antiarrhythmic drug therapy to prevent recurrence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Role of anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to embolic risk, which is clearly greater in patients who also have AF, and anticoagulation are discussed separately. Most patients are managed the same as those with AF. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/40/37511?source=see_link\">",
"     \"Embolic risk and the role of anticoagulation in atrial flutter\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=see_link\">",
"     \"Antithrombotic therapy to prevent embolization in atrial fibrillation\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/1\">",
"      Crijns HJ, Van Gelder IC, Tieleman RG, et al. Long-term outcome of electrical cardioversion in patients with chronic atrial flutter. Heart 1997; 77:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/2\">",
"      Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006; 48:e149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/3\">",
"      Singh S, Zoble RG, Yellen L, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation 2000; 102:2385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/4\">",
"      Wells JL Jr, MacLean WA, James TN, Waldo AL. Characterization of atrial flutter. Studies in man after open heart surgery using fixed atrial electrodes. Circulation 1979; 60:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/5\">",
"      Klein GJ, Guiraudon GM, Sharma AD, Milstein S. Demonstration of macroreentry and feasibility of operative therapy in the common type of atrial flutter. Am J Cardiol 1986; 57:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/6\">",
"      Cosio FG, Arribas F, Barbero JM, et al. Validation of double-spike electrograms as markers of conduction delay or block in atrial flutter. Am J Cardiol 1988; 61:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/7\">",
"      Cosio FG, L&oacute;pez-Gil M, Goicolea A, Arribas F. Electrophysiologic studies in atrial flutter. Clin Cardiol 1992; 15:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/8\">",
"      Olshansky B, Okumura K, Hess PG, Waldo AL. Demonstration of an area of slow conduction in human atrial flutter. J Am Coll Cardiol 1990; 16:1639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/9\">",
"      Touboul P, Saoudi N, Atallah G, Kirkorian G. Electrophysiologic basis of catheter ablation in atrial flutter. Am J Cardiol 1989; 64:79J.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/10\">",
"      Feld GK, Fleck RP, Chen PS, et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 1992; 86:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/11\">",
"      Kirkorian G, Moncada E, Chevalier P, et al. Radiofrequency ablation of atrial flutter. Efficacy of an anatomically guided approach. Circulation 1994; 90:2804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/12\">",
"      Olgin JE, Kalman JM, Fitzpatrick AP, Lesh MD. Role of right atrial endocardial structures as barriers to conduction during human type I atrial flutter. Activation and entrainment mapping guided by intracardiac echocardiography. Circulation 1995; 92:1839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/13\">",
"      Poty H, Saoudi N, Abdel Aziz A, et al. Radiofrequency catheter ablation of type 1 atrial flutter. Prediction of late success by electrophysiological criteria. Circulation 1995; 92:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/14\">",
"      Cauchemez B, Haissaguerre M, Fischer B, et al. Electrophysiological effects of catheter ablation of inferior vena cava-tricuspid annulus isthmus in common atrial flutter. Circulation 1996; 93:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/15\">",
"      Nath S, Mounsey JP, Haines DE, DiMarco JP. Predictors of acute and long-term success after radiofrequency catheter ablation of type 1 atrial flutter. Am J Cardiol 1995; 76:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/16\">",
"      Steinberg JS, Prasher S, Zelenkofske S, Ehlert FA. Radiofrequency catheter ablation of atrial flutter: procedural success and long-term outcome. Am Heart J 1995; 130:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/17\">",
"      Fischer B, Haissaguerre M, Garrigues S, et al. Radiofrequency catheter ablation of common atrial flutter in 80 patients. J Am Coll Cardiol 1995; 25:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/18\">",
"      Schmitt H, Weber S, Tillmanns H, Waldecker B. Diagnosis and ablation of atrial flutter using a high resolution, noncontact mapping system. Pacing Clin Electrophysiol 2000; 23:2057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/19\">",
"      Nabar A, Rodriguez LM, Timmermans C, et al. Isoproterenol to evaluate resumption of conduction after right atrial isthmus ablation in type I atrial flutter. Circulation 1999; 99:3286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/20\">",
"      Poty H, Saoudi N, Nair M, et al. Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of isthmus block: application to ablation during sinus rhythm. Circulation 1996; 94:3204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/21\">",
"      Schwartzman D, Callans DJ, Gottlieb CD, et al. Conduction block in the inferior vena caval-tricuspid valve isthmus: association with outcome of radiofrequency ablation of type I atrial flutter. J Am Coll Cardiol 1996; 28:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/22\">",
"      Chen SA, Chiang CE, Wu TJ, et al. Radiofrequency catheter ablation of common atrial flutter: comparison of electrophysiologically guided focal ablation technique and linear ablation technique. J Am Coll Cardiol 1996; 27:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/23\">",
"      Nakagawa H, Lazzara R, Khastgir T, et al. Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter. Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation 1996; 94:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/24\">",
"      Passman RS, Kadish AH, Dibs SR, et al. Radiofrequency ablation of atrial flutter: a randomized controlled study of two anatomic approaches. Pacing Clin Electrophysiol 2004; 27:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/25\">",
"      Kottkamp H, H&uuml;gl B, Krauss B, et al. Electromagnetic versus fluoroscopic mapping of the inferior isthmus for ablation of typical atrial flutter: A prospective randomized study. Circulation 2000; 102:2082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/26\">",
"      Scheinman MM, Huang S. The 1998 NASPE prospective catheter ablation registry. Pacing Clin Electrophysiol 2000; 23:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/27\">",
"      Calkins H, Canby R, Weiss R, et al. Results of catheter ablation of typical atrial flutter. Am J Cardiol 2004; 94:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/28\">",
"      Sparks PB, Jayaprakash S, Vohra JK, et al. Left atrial \"stunning\" following radiofrequency catheter ablation of chronic atrial flutter. J Am Coll Cardiol 1998; 32:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/29\">",
"      Welch PJ, Afridi I, Joglar JA, et al. Effect of radiofrequency ablation on atrial mechanical function in patients with atrial flutter. Am J Cardiol 1999; 84:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/30\">",
"      Anselme F, Saoudi N, Poty H, et al. Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block. Circulation 1999; 99:534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/31\">",
"      Ng DW, Altemose GT, Wu Q, et al. Typical atrial flutter as a risk factor for the development of atrial fibrillation in patients without otherwise demonstrable atrial tachyarrhythmias. Mayo Clin Proc 2008; 83:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/32\">",
"      Paydak H, Kall JG, Burke MC, et al. Atrial fibrillation after radiofrequency ablation of type I atrial flutter: time to onset, determinants, and clinical course. Circulation 1998; 98:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/33\">",
"      Ellis K, Wazni O, Marrouche N, et al. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence. J Cardiovasc Electrophysiol 2007; 18:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/34\">",
"      Luchsinger JA, Steinberg JS. Resolution of cardiomyopathy after ablation of atrial flutter. J Am Coll Cardiol 1998; 32:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/35\">",
"      Lee SH, Tai CT, Yu WC, et al. Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter. Am J Cardiol 1999; 84:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/36\">",
"      O'Callaghan PA, Meara M, Kongsgaard E, et al. Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter. Heart 2001; 86:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/37\">",
"      Natale A, Newby KH, Pisan&oacute; E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol 2000; 35:1898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/38\">",
"      Newby KH, Zimerman L, Wharton JM, et al. Radiofrequency ablation of atrial flutter and atrial tachycardias in patients with permanent indwelling catheters. Pacing Clin Electrophysiol 1996; 19:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/39\">",
"      Wazni O, Marrouche NF, Martin DO, et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation 2003; 108:2479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/40\">",
"      Waldo AI, Cooper TB. Spontaneous onset of type I atrial flutter in patients. J Am Coll Cardiol 1996; 28:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/41\">",
"      Waldo AL. Mechanisms of atrial flutter and atrial fibrillation: distinct entities or two sides of a coin? Cardiovasc Res 2002; 54:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/42\">",
"      Kilicaslan F, Verma A, Yamaji H, et al. The need for atrial flutter ablation following pulmonary vein antrum isolation in patients with and without previous cardiac surgery. J Am Coll Cardiol 2005; 45:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/43\">",
"      Ja&iuml;s P, Shah DC, Ha&iuml;ssaguerre M, et al. Mapping and ablation of left atrial flutters. Circulation 2000; 101:2928.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24888/abstract/44\">",
"      Marrouche NF, Natale A, Wazni OM, et al. Left septal atrial flutter: electrophysiology, anatomy, and results of ablation. Circulation 2004; 109:2440.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1065 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-B6AD6E7C64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24888=[""].join("\n");
var outline_f24_19_24888=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHARMACOLOGIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RF ABLATION IN TYPE I ATRIAL FLUTTER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Technique of ablation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Role of intracardiac echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Electroanatomic mapping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Outcome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Atrial stunning after ablation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Recurrent flutter or AF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Improvement in left ventricular function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Quality of life",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Ablation versus pharmacologic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Ablation in patients with implantable devices",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pulmonary vein isolation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Left atrial flutter after PVI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Prior cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      RF ABLATION IN TYPE II ATRIAL FLUTTER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Role of anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1065\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1065|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?35/57/36766\" title=\"algorithm 1\">",
"      Algorithm for the maintenance of sinus rhythm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1065|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/10/27811\" title=\"figure 1\">",
"      Flutter circuit right atrium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1065|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/49/13084\" title=\"table 1A\">",
"      Electrical cardioversion AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/39/25212\" title=\"table 1B\">",
"      Pharmacologic cardioversion AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/21/38236\" title=\"table 1C\">",
"      ACC AHA ESC doses conversion AF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/39/26236\" title=\"table 2\">",
"      ACC AHA ESC drugs maintain NSR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1065|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?16/5/16470\" title=\"waveform 1A\">",
"      EP study tracings RF ablation atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?7/47/7926\" title=\"waveform 1B\">",
"      EP study tracings bidirectional isthmus block",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/24/12682?source=related_link\">",
"      Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/28/20938?source=related_link\">",
"      Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/32/42506?source=related_link\">",
"      Antithrombotic therapy to prevent embolization in atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28602?source=related_link\">",
"      Atrial fibrillation and flutter after cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/25/19866?source=related_link\">",
"      Catheter ablation of cardiac arrhythmias: Overview and technical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18328?source=related_link\">",
"      Control of ventricular rate in atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/53/15192?source=related_link\">",
"      Electrocardiographic and electrophysiologic features of type I atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/56/12165?source=related_link\">",
"      Electrocardiographic and electrophysiologic features of type II atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/40/37511?source=related_link\">",
"      Embolic risk and the role of anticoagulation in atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/28/6601?source=related_link\">",
"      Hemodynamic consequences of atrial fibrillation and cardioversion to sinus rhythm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40938?source=related_link\">",
"      Radiofrequency catheter ablation to prevent recurrent atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/49/18201?source=related_link\">",
"      Restoration of sinus rhythm in atrial flutter",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5817?source=related_link\">",
"      Rhythm control versus rate control in atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_19_24889="General principles of the use of intracoronary stents";
var content_f24_19_24889=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   General principles of the use of intracoronary stents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24889/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24889/contributors\">",
"     Thomas Levin, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24889/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24889/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24889/contributors\">",
"     Stephan Windecker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24889/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24889/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/19/24889/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Percutaneous coronary intervention (PCI) refers to both non-stent procedures on one or more coronary arteries such as balloon angioplasty or atherectomy as well as stent interventions. The introduction of balloon angioplasty, formally termed percutaneous transluminal coronary angioplasty (PTCA), in the 1970s provided a nonsurgical revascularization alternative to coronary artery bypass graft surgery (CABG). However, acute arterial recoil and coronary dissection were early and potentially fatal complications of the procedure and angiographic restenosis occurred in approximately 40 percent of patients at six months, 50 to 75 percent of whom had recurrent ischemic symptoms. Accordingly, 20 to 30 percent of patients required repeat revascularization of the initially treated lesion within the first year after balloon angioplasty. Recurrent ischemic symptoms after one year were most often due to a new or progressive lesion; the initially treated lesion remained stable or actually regressed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bare metal stents (BMS) were developed to prevent abrupt artery closure due to recoil or dissection following balloon angioplasty and they succeeded in doing so. Acute closure has been reduced from 2 to 10 percent with PTCA alone to &lt;1 percent in the stent era and has resulted in a lower rate of periprocedural myocardial infarction. In the stent era, PCI became safer with low rates of periprocedural myocardial infarction (MI) and emergency CABG.",
"   </p>",
"   <p>",
"    As a result, stenting became the standard of care for percutaneous coronary interventions, with balloon angioplasty alone being used only in situations where a stent could not be delivered to the targeted lesion. With refinement of stent design and implantation technique, the rate of clinically-indicated target lesion revascularization at one year after BMS placement fell to between 10 and 20 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. The rate has fallen further with the placement of drug-eluting stents in many patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link&amp;anchor=H2#H2\">",
"     \"Intracoronary stent restenosis\", section on 'Incidence of restenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The types of stents, issues related to stent deployment, periprocedural medication use, and a few related topics will be reviewed here. Issues related to antithrombotic therapy, complications of stenting, the efficacy of drug-eluting stents, and the use of stenting in specific coronary lesions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/37/41562?source=see_link\">",
"     \"Antithrombotic therapy for intracoronary stent implantation: Clinical trials\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link\">",
"     \"Periprocedural complications of percutaneous coronary intervention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=see_link\">",
"     \"Drug-eluting intracoronary stents: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TYPES OF STENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a variety of types of intracoronary stents [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. In general, stents can be characterized according to material composition, thickness of struts, and whether or not they are capable of eluting drugs for local delivery (",
"    <a class=\"graphic graphic_table graphicRef65603 \" href=\"UTD.htm?11/39/11901\">",
"     table 1",
"    </a>",
"    ). Stent design may also be specific for certain indications such as small (&lt;2.5 mm diameter) vessels or lesions involving a bifurcation of a main vessel and side branch.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H689098340\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR STENTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for stenting are discussed in separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/38/27240?source=see_link\">",
"     \"Bypass surgery versus percutaneous intervention in the management of stable angina pectoris: Recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31721?source=see_link\">",
"     \"Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Periprocedural management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=see_link\">",
"     \"Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4426?source=see_link\">",
"     \"Management of left main coronary artery disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42343?source=see_link\">",
"     \"Management of significant proximal left anterior descending coronary artery disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30970?source=see_link\">",
"     \"Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/22/17770?source=see_link\">",
"     \"Use of intracoronary stents for specific coronary lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TECHNICAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of stents is limited by vessel anatomy and sometimes arterial diameter. Vessels smaller than 2.0 mm are not ideal for stenting. Tortuous, angulated, and calcified arterial segments continue to pose challenges for even the newest stent designs because of inability to deliver the stent to the target lesion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=see_link\">",
"     \"Drug-eluting intracoronary stents: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Coronary stents are delivered and deployed on balloon catheters (",
"    <a class=\"graphic graphic_figure graphicRef52634 \" href=\"UTD.htm?10/12/10434\">",
"     figure 1",
"    </a>",
"    ), which are inserted via the femoral or the radial artery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Optimal stenting",
"    </span>",
"    &nbsp;&mdash;&nbsp;The single most important contribution to stenting efficacy is to achieve full expansion of the arterial lumen (so-called optimal stenting). Attainment of a large luminal diameter minimizes the risk of both stent thrombosis and restenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Suboptimal luminal dilation is due both to inadequate balloon expansion, which is related in part to plaque characteristics, poor technique, or to elastic recoil, which is associated with stent design and resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link\">",
"     \"Periprocedural complications of percutaneous coronary intervention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We agree with the 2011 American College of Cardiology",
"    <span class=\"nowrap\">",
"     Foundation/American",
"    </span>",
"    Heart",
"    <span class=\"nowrap\">",
"     Association/Society",
"    </span>",
"    for Cardiovascular Angiography and Intervention",
"    <span class=\"nowrap\">",
"     (ACCF/AHA/SCAI)",
"    </span>",
"    Guideline Update for Percutaneous Coronary Intervention which states &ldquo;&hellip;a minimum diameter stenosis of &lt;10 percent (with an optimal goal of as close to 0 percent as possible) should be the new benchmark for lesions treated with coronary stenting. As with balloon angioplasty, there should be final TIMI low grade 3, without occlusion of a significant side branch, flow-limiting dissection, distal embolization, or angiographic thrombus&hellip;&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The deleterious effects of suboptimal stenting were illustrated in the STARS trial in which 16 percent of patients who underwent stenting were excluded from the randomized study because of a suboptimal result (defined as residual stenosis &gt;10 percent, evidence of stent thrombosis, dissection or abrupt closure, absence of TIMI III flow, or need for three or more stents) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/11\">",
"     11",
"    </a>",
"    ]. Those with suboptimal stenting had the following differences in outcome compared to patients who achieved an optimal stent result:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An increase in the periprocedural non-ST elevation MI (8.7 versus 4.2 percent), overall 30-day mortality (1.1 versus 0.06 percent), and clinical restenosis (27 versus 16 percent); the last effect was associated with a smaller final lumen diameter and the use of multiple stents.",
"     </li>",
"     <li>",
"      At nine months, an increased incidence of major cardiac events (death, MI, target lesion revascularization), largely due to increases in non-ST elevation MI (9 versus 4.6 percent), and the need for target vessel revascularization (15.5 versus 10.2 percent).",
"     </li>",
"     <li>",
"      These findings have been supported by other data from the drug-eluting stent era, wherein stent underexpansion has been associated with adverse late outcomes [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/12,13\">",
"       12,13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Predilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Predilation of the lesion is performed in most cases. Direct stenting, an alternative, may be reasonable based upon anticipated ease of delivery and deployment. Should predilation suggest that the lesion is not \"dilatable,\" an alternative strategy such as rotational atherectomy, high-pressure noncompliant balloon dilatation, or not placing a stent needs to be considered. Angiographic predictors of inability to predilate include moderate coronary calcification, heavy plaque burden, or diffuse coronary artery disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H546978945\">",
"    <span class=\"h3\">",
"     Direct stenting without predilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The availability of low-profile stent-delivery systems has led to the consideration of direct stenting (ie, without predilation). Although stenting reduces the incidence of restenosis after PTCA, the classic approach of predilation, stent deployment, and high-pressure postdilation is associated with increased procedure duration, more radiation exposure and contrast use, and increased cost compared to direct stenting [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Settings in which direct stenting might be considered include [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Vessel &ge;2.5 mm in diameter",
"     </li>",
"     <li>",
"      Proximal lesion location",
"     </li>",
"     <li>",
"      Absence of severe coronary calcification",
"     </li>",
"     <li>",
"      Absence of significant angulation (bend &gt;45&ordm;)",
"     </li>",
"     <li>",
"      Absence of very severe lesions and bifurcation lesions",
"     </li>",
"     <li>",
"      ST-elevation myocardial infarction",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of randomized clinical trials (BET, SWIBAP, PREDICT, CONVERTIBLE, and TRENDS) have compared direct stenting to stenting after balloon dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. Major outcomes were similar, including procedural success (although 6 to 14 percent of patients in the direct stenting group required predilation because of an inability to cross the lesion), adverse effects, and major cardiac events at follow-up. The authors of PREDICT concluded that direct stenting was safe and successful, but offered only modest cost savings and no reduction in late restenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Proponents of the traditional approach of using predilation before stenting argue that predilation with an appropriately sized balloon ensures that the lesion is indeed expandable, thereby ensuring optimal stent deployment. When predilation fails to expand the lesion, the operator may then choose to use supplemental techniques such as atherectomy device or more aggressive predilation. &nbsp;",
"   </p>",
"   <p>",
"    Given the limited advantages and potential risks, we favor predilation in most lesions. One possible exception is in degenerated saphenous vein grafts. In this situation, each balloon dilatation is associated with a risk of embolization of degenerated graft material and obstruction of the coronary microcirculation and its consequences",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     High pressure balloon dilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A major strategy to attain optimal stent deployment is high-pressure balloon dilation during or after stent deployment. Initial studies showed clear improvement in stent expansion and apposition with high-pressure dilation post-stenting [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. These observations provided the basis for modern stenting techniques using routine high-pressure dilation in addition to antiplatelet therapy to prevent stent thrombosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/37/41562?source=see_link\">",
"     \"Antithrombotic therapy for intracoronary stent implantation: Clinical trials\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stents are usually deployed with a high-pressure technique utilizing &ge;12 to 16 atm. Lower pressure deployment (8 to 14 atm) is indicated when there is significant vessel tapering or when proximal edge injury is a concern, as is the case with use of drug-eluting stents. In most cases, we perform high-pressure postdilation with an appropriately sized noncompliant balloon at 12 to 16 atm to achieve full stent expansion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     IVUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravascular ultrasound (IVUS, also called intracoronary ultrasound) allows the operator to visualize how well the stent is deployed and to quantitate the residual luminal diameter [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/21,24\">",
"     21,24",
"    </a>",
"    ]. However, it is uncertain if routine IVUS is necessary for optimal stent deployment when high-pressure techniques are used. Initial observational studies suggested a reduction in the need for target vessel revascularization from routine IVUS guidance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/22,25\">",
"     22,25",
"    </a>",
"    ], but the results from subsequent randomized trials are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/26-30\">",
"     26-30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/27/34234?source=see_link&amp;anchor=H321553541#H321553541\">",
"     \"Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation\", section on 'Intravascular ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    AVID is the largest randomized trial to address this issue [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/30\">",
"     30",
"    </a>",
"    ]. In this study, 800 patients were randomly assigned after elective bare-metal stent placement with an optimal angiographic result to either angiography or IVUS directed therapy. All patients received IVUS, but the results were available only to operators of patients in the IVUS directed therapy group. IVUS criteria for optimal stent placement (&lt;10 percent area stenosis, apposition, and absence of dissection) were used to decide upon further therapy. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The overall rate of target lesion revascularization (TLR) was not significantly lower in the IVUS group (8.1 versus 12.0 percent) at 12 months.",
"     </li>",
"     <li>",
"      There were two subgroups of patients in whom IVUS was associated with lower TLR at 12 months: those with vessels with a distal reference diameter &ge;2.5 mm (4.3 versus 10.1 percent), and those with a prestent angiographic stenosis of &ge;70 percent (3.1 versus 14.2 percent).",
"     </li>",
"     <li>",
"      In the IVUS group, only 37 percent of patients with inadequate stent expansion (&lt;90 percent) received further therapy to optimize the final result.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The potential value of IVUS with stenting of long lesions (&gt;20 mm) was demonstrated in the TULIP trial [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/31\">",
"     31",
"    </a>",
"    ]. At 12 months, IVUS guidance was associated with significant reductions in angiographic restenosis (23 versus 45 percent without IVUS) and in target lesion revascularization (10 versus 23 percent).",
"   </p>",
"   <p>",
"    IVUS has also been helpful in evaluating the etiology of persistent haziness, observed in 15 percent of patients undergoing high-pressure stent deployment (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76521 \" href=\"UTD.htm?17/18/17696\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/32\">",
"     32",
"    </a>",
"    ]. Causes of this finding include unrecognized residual plaque or angiographically occult dissection. All of these factors are important for long-term success.",
"   </p>",
"   <p>",
"    The optimal use of IVUS after stent placement is unknown. Due to the added time and expense, and lack of availability in many interventional laboratories, IVUS tends to be performed in only a small proportion of patients, although use varies considerably between centers. It is most useful when under-expansion is suspected on coronary angiography, with long lesions, when the final size goal is uncertain, or when stent expansion is expected to be difficult, as with calcified lesions or a lesion in the left main coronary artery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IVUS may be especially valuable when patients develop restenosis or thrombosis, particularly if these events develop as a result of stent under-expansion. Additionally, in selected patients, stent thrombosis is due to disease progression just proximal or distal to the stent. Such lesions can be identified by IVUS and are typically treated with an additional stent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6097273\">",
"    <span class=\"h3\">",
"     Optical coherence tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optical coherence tomography has a higher spatial resolution than IVUS. However, we agree with the 2011",
"    <span class=\"nowrap\">",
"     ACCF/AHA/SCAI",
"    </span>",
"    Guideline Update for Percutaneous Coronary Intervention which states &ldquo;the appropriate role of optical coherence tomography in routine clinical decision making has not been established&hellip;&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/27/34234?source=see_link&amp;anchor=H321552326#H321552326\">",
"     \"Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation\", section on 'Optical coherence tomography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Coronary flow reserve measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coronary artery Doppler measurements can be used to assess whether optimal stenting has been achieved. Two measurements have been evaluated: the relative coronary flow velocity reserve and the coronary pressure-derived myocardial fractional flow reserve.",
"   </p>",
"   <p>",
"    The coronary pressure-derived myocardial fractional flow reserve (FFRmyo) compares the intracoronary pressure distal to the stented site (measured with a specially designed angioplasty guidewire) to the aortic root pressure measured through the guiding catheter during maximal hyperemic flow produced by bolus intracoronary adenosine injection or a continuous intravenous infusion. It is an easy, inexpensive, and rapidly obtainable index. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13672?source=see_link\">",
"     \"Clinical use of coronary artery pressure and Doppler flow measurements\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prognostic effect of the FFRmyo has been demonstrated in several studies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. In the largest series, FFRmyo was measured in 750 patients who had undergone apparently satisfactory stent implantation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/33\">",
"     33",
"    </a>",
"    ]. At six months, adverse cardiac events occurred in 10 percent, primarily target vessel revascularization (70 percent) and MI (25 percent). By multivariate analysis, the FFR was the major independent predictor of adverse events. At a normal FFR (&gt;0.95) adverse events occurred in 4.9 percent compared to 6.2, 20.3, and 29.5 percent, respectively, for FFR between 0.90 and 0.95, &lt;0.9 and &lt;0.80.",
"   </p>",
"   <p>",
"    Although these methods are useful to predict optimal stent result and predict future events, they are seldom used for this purpose, for which most operators rely on angiographic appearance or IVUS.",
"   </p>",
"   <p>",
"    A separate issue is the value of the routine use of FFRmyo before PCI on all lesions deemed to require PCI using angiographic criteria. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13672?source=see_link&amp;anchor=H11#H11\">",
"     \"Clinical use of coronary artery pressure and Doppler flow measurements\", section on 'Multivessel disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20877214\">",
"    <span class=\"h2\">",
"     Hospital and operator volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient outcomes after PCI are influenced by laboratory and operator volumes and by the availability of onsite cardiac surgery. The 2011",
"    <span class=\"nowrap\">",
"     ACCF/AHA/SCAI",
"    </span>",
"    Guideline Update for Percutaneous Coronary Intervention made recommendations about operator and hospital volume, and the importance of onsite cardiac surgery for both elective and primary PCI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link&amp;anchor=H3#H3\">",
"     \"Periprocedural complications of percutaneous coronary intervention\", section on 'Influence of hospital and operator volume'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link&amp;anchor=H7#H7\">",
"     \"Periprocedural complications of percutaneous coronary intervention\", section on 'Mortality at one year'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99799642\">",
"    <span class=\"h2\">",
"     Robotic PCI",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential use of a robotic-enhanced PCI system is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link&amp;anchor=H35#H35\">",
"     \"Periprocedural complications of percutaneous coronary intervention\", section on 'Radiation exposure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20875800\">",
"    <span class=\"h1\">",
"     ADJUNCTIVE MEDICAL THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Antithrombotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients undergoing PCI are given combined anticoagulant and antiplatelet therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , a platelet P2Y12 receptor blocker,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/48/18184?source=see_link\">",
"     bivalirudin",
"    </a>",
"    , and, in a minority of cases, a glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/10,36\">",
"     10,36",
"    </a>",
"    ]. The data supporting the use of these drugs and the recommended regimen are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/37/41562?source=see_link\">",
"     \"Antithrombotic therapy for intracoronary stent implantation: Clinical trials\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/8/27786?source=see_link\">",
"     \"Antithrombotic therapy for percutaneous coronary intervention: General use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Statin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statin therapy improves the outcome of patients with either stable or unstable coronary disease treated medically. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/59/3002?source=see_link\">",
"     \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33656?source=see_link\">",
"     \"Cholesterol lowering after an acute coronary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A benefit from statin therapy at the time of PCI has also been demonstrated, as established below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20876631\">",
"    <span class=\"h3\">",
"     Before PCI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benefit from statin therapy prior to PCI, as evidenced by a reduction in periprocedural MI, has been shown in a multiple randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/37-42\">",
"     37-42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The benefit from initiation of statin therapy prior to PCI in patients with ACS was evaluated in the ARMYDA-ACS trial of 171 patients with NSTEMI scheduled to undergo urgent, but not emergent, PCI [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/42\">",
"       42",
"      </a>",
"      ]. The patients were randomly assigned to either 80 mg of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"       atorvastatin",
"      </a>",
"      12 hours before the procedure with an additional preprocedural dose of 40 mg, or to matching placebo; all patients received 40 mg of atorvastatin daily thereafter. The primary outcome of 30-day major adverse cardiac events (death, MI, or unplanned revascularization) occurred significantly less often in the early atorvastatin group (5 versus 17 percent, odds ratio 0.12, 95% CI 0.05-0.50). The difference was due almost entirely to a lowering of the incidence of MI, defined as important CK-MB elevation.",
"     </li>",
"     <li>",
"      In the ARMYDA trial of 153 stable patients were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"       atorvastatin",
"      </a>",
"      40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      or placebo starting seven days before the procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/37\">",
"       37",
"      </a>",
"      ]. Cardiac biomarkers were measured at baseline and at 8 and 24 hours after the procedure. Patients pretreated with atorvastatin had a significantly lower incidence of myocardial injury as detected by elevation in serum creatine kinase MB (12 versus 35 percent) and troponin I (20 versus 48 percent).",
"     </li>",
"     <li>",
"      In the open label NAPLES II trial 668 stable, statin-naive patients were randomly assigned to either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"       atorvastatin",
"      </a>",
"      80 or no therapy 24 hours before PCI [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/41\">",
"       41",
"      </a>",
"      ]. Cardiac biomarkers were measured at baseline and at 8 and 24 hours after the procedure. The primary endpoint of periprocedural MI (CK-MB elevation &gt;3 X ULN) was significantly lower in the atorvastatin group (9.5 versus 15.8 percent; odds ratio 0.56, 95% CI 0.36-0.89).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     After PCI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statin therapy has both short- and long-term benefits when administered after PCI with stenting [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The PROVE-IT TIMI 22 trial demonstrated that the use of intensive statin therapy (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"       atorvastatin",
"      </a>",
"      80 mg), as opposed to less intensive therapy (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/27/25016?source=see_link\">",
"       pravastatin",
"      </a>",
"      40 mg), after PCI in patients with acute coronary syndromes resulted in a significantly lower combined rate of all cause mortality, myocardial infarction, unstable angina, and revascularization after 30 days (21.5 versus 26.5 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/43\">",
"       43",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33656?source=see_link&amp;anchor=H4#H4\">",
"       \"Cholesterol lowering after an acute coronary syndrome\", section on 'PROVE IT-TIMI 22 trial'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In the LIPS trial 1677 patients with stable or unstable angina or silent ischemia with serum total cholesterol between 135 and 270",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (3.5 to 7.0",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      were randomly assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8264?source=see_link\">",
"       fluvastatin",
"      </a>",
"      (80",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      or placebo after successful completion of their first PCI [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/44\">",
"       44",
"      </a>",
"      ]. At a median follow-up of 3.9 years, fluvastatin therapy was associated with a significant reduction in major adverse cardiac events, defined as any cardiac death, nonfatal MI, or a reintervention procedure (21.4 versus 26.7 percent). The benefit began at 1.5 years, was independent of baseline serum total cholesterol, and was seen in diabetics and those with multivessel disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There was no evidence of a reduction in restenosis in the LIPS trial. Thus, the benefit appeared to be unrelated to the stent site, and may have been due to actions (such as plaque stabilization) elsewhere in the coronary circulation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/2/32?source=see_link\">",
"     \"Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/25/29081?source=see_link&amp;anchor=H16#H16\">",
"     \"Possible role of long-term medical therapies to prevent restenosis following percutaneous coronary intervention\", section on 'Statins'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The issue of whether patients on chronic statin therapy scheduled to undergo PCI benefit from an acute dose of statin was addressed in the ARMYDA-RECAPTURE trial [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/46\">",
"     46",
"    </a>",
"    ]. In this study 383 patients, of whom 53 percent had stable angina, were randomly assigned to either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    reload (80 mg 12 hours before the intervention, with a further 40 mg preprocedure dose) or placebo. The primary endpoint of 30-day major adverse cardiovascular events (cardiac death, MI, or unplanned revascularization) occurred significantly less often in the atorvastatin reload group (3.7 versus 9.4 percent), driven mostly by a reduction in periprocedural MI. In subset analysis, the benefit was seen principally in patients with ACS (3.3 versus 14.8 percent), but not in those with stable angina (4.0 versus 4.9 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33656?source=see_link\">",
"     \"Cholesterol lowering after an acute coronary syndrome\"",
"    </a>",
"    .) Whether routine reloading with a statin should be considered standard of care is yet to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20877064\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of periprocedural complications, both cardiac and noncardiac, can occur after PCI with stenting. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link\">",
"     \"Periprocedural complications of percutaneous coronary intervention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10018511\">",
"    <span class=\"h2\">",
"     Restenosis versus stent thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;After a successful procedure, coronary stents can fail to maintain vessel patency due to either restenosis or stent thrombosis.&nbsp;Restenosis is a gradual re-narrowing of the stented segment that occurs mostly between 3 to 12 months after stent placement. It usually presents as recurrent angina but can present as acute MI in approximately 10 percent of patients. It can usually be managed by repeat percutaneous revascularization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=see_link\">",
"     \"Intracoronary stent restenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, stent thrombosis is an abrupt thrombotic occlusion of a previously widely patent stent.&nbsp;It is a catastrophic complication that presents as sudden death or large myocardial infarction in most patients.&nbsp;Despite successful repeat revascularization, the six-month mortality is high. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10634?source=see_link\">",
"     \"Antiplatelet therapy after coronary artery stenting\"",
"    </a>",
"    .)&nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20877078\">",
"    <span class=\"h1\">",
"     TIMING OF DISCHARGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;We believe it is reasonable to discharge low-risk patients after four to eight hours of observation if no complications or concerns have arisen.",
"   </p>",
"   <p>",
"    A 2013 meta-analysis of five randomized trials (2039 patients) and eight observational studies (109,791 patients) with substantial heterogeneity compared same-day discharge (SSD) to overnight hospitalization (ON) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/47\">",
"     47",
"    </a>",
"    ]. Most patients were at low-risk of a complication: very few had an acute coronary syndrome, many had single vessel disease, and most did not have an intraprocedural complication [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/48\">",
"     48",
"    </a>",
"    ]. The primary outcomes were the incidence of total complications, major adverse cardiovascular events, and rehospitalization within 30 days. With regard to the incidence of total complications within 30 days, there was no significant difference between SSD and ON in either the randomized trials or observational studies (odds ratio [OR] 1.2, 95% CI 0.82-1.74 and 0.67, 95% CI 0.27-1.66, comparing SSD with ON, respectively). There was no significant difference between the two approaches with regard to major adverse cardiovascular events or rehospitalization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SAFETY OF MRI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any ferromagnetic object within the body represents a potential hazard when exposed to the strong magnetic field of a magnetic resonance imaging (MRI) system. Based upon available evidence, it appears to be safe to perform an MRI at any time after placement of coronary artery stents of any type. The discussion of this issue is found elsewhere.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H614900546\">",
"    <span class=\"h1\">",
"     ANTIMICROBIAL PROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracoronary stenting is not an indication for antimicrobial prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24889/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     RISK OF EARLY NONCARDIAC SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in patients receiving bare-metal stents have shown that major noncardiac surgery within six weeks, and particularly within two weeks, of stenting is associated with an appreciable risk of stent thrombosis that is often associated with cessation of or a reduction in antiplatelet therapy to minimize bleeding risk. Limited data for drug-eluting stents suggest a similar risk. In contrast, balloon angioplasty alone appears to be associated with a low incidence of cardiac death or MI when performed a few weeks before noncardiac surgery. This issue is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6344?source=see_link&amp;anchor=H350963316#H350963316\">",
"     \"Elective noncardiac surgery after percutaneous coronary intervention\", section on 'Our approach'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/24/39298?source=see_link\">",
"       \"Patient information: Angioplasty and stenting for the heart (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?17/38/18020?source=see_link\">",
"       \"Patient information: Heart stents and angioplasty (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20875816\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stents should be deployed with a goal of achieving minimal residual stenosis (so-called optimal stenting). Attainment of a large luminal diameter minimizes the risk of both stent thrombosis and restenosis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Optimal stenting'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although direct stenting has some advantages, predilation is recommended for the majority of lesions. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Predilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In most cases, we perform high-pressure stent deployment or postdilation at 12 to 16 atm to achieve full stent expansion. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'High pressure balloon dilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      IVUS can be a useful adjunct to guide stent placement. However, with the routine use of higher stent-deployment pressures and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      plus a platelet P2Y12 receptor blocker, very few institutions use IVUS as part of their routine practice for stent placement. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'IVUS'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Physiologic assessment with coronary artery Doppler flow velocity measurement or pressure wire can be used to assess the adequacy of stent implantation. The presence of a myocardial fractional flow reserve &gt;0.95 (the ratio of distal coronary to aortic pressure during adenosine infusion) correlates with a large stent cross-sectional area and a reduced risk of subsequent restenosis. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Coronary flow reserve measurements'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Statin therapy improves the outcome of patients with either stable or unstable coronary disease treated medically. Virtually all patients undergoing PCI should be on chronic statin therapy. The role of statin reloading remains unclear. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Statin therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/59/3002?source=see_link\">",
"       \"Intensity of lipid lowering therapy in secondary prevention of coronary heart disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33656?source=see_link\">",
"       \"Cholesterol lowering after an acute coronary syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients undergoing elective stent therapy are generally discharged within 24 hours after stent implantation following overnight observation and monitoring. Same day discharge may be appropriate for some patients, including those who have an uncomplicated procedure and are at low risk of subsequent complication. (See",
"      <a class=\"local\" href=\"#H20877078\">",
"       'Timing of discharge'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H360576976\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and editors would like to thank Dr. David O. Williams for his contributions as a Section Editor to previous versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/1\">",
"      Ormiston JA, Stewart FM, Roche AH, et al. Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study. Circulation 1997; 96:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/2\">",
"      Guiteras-Val P, Varas-Lorenzo C, Garcia-Picart J, et al. Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol 1999; 83:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/3\">",
"      Cannan CR, Yeh W, Kelsey SF, et al. Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Am J Cardiol 1999; 84:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/4\">",
"      Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/5\">",
"      Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/6\">",
"      Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 2002; 40:2082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/7\">",
"      Oesterle SN, Whitbourn R, Fitzgerald PJ, et al. The stent decade: 1987 to 1997. Stanford Stent Summit faculty. Am Heart J 1998; 136:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/8\">",
"      Colombo A, Stankovic G, Moses JW. Selection of coronary stents. J Am Coll Cardiol 2002; 40:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/9\">",
"      Bermejo J, Botas J, Garc&iacute;a E, et al. Mechanisms of residual lumen stenosis after high-pressure stent implantation: a quantitative coronary angiography and intravascular ultrasound study. Circulation 1998; 98:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/10\">",
"      Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124:e574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/11\">",
"      Cutlip DE, Leon MB, Ho KK, et al. Acute and nine-month clinical outcomes after \"suboptimal\" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry. J Am Coll Cardiol 1999; 34:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/12\">",
"      Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 2004; 43:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/13\">",
"      Doi H, Maehara A, Mintz GS, et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv 2009; 2:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/14\">",
"      Briguori C, Sheiban I, De Gregorio J, et al. Direct coronary stenting without predilation. J Am Coll Cardiol 1999; 34:1910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/15\">",
"      Wilson SH, Berger PB, Mathew V, et al. Immediate and late outcomes after direct stent implantation without balloon predilation. J Am Coll Cardiol 2000; 35:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/16\">",
"      Carri&eacute; D, Khalif&eacute; K, Citron B, et al. Comparison of direct coronary stenting with and without balloon predilatation in patients with stable angina pectoris. BET (Benefit Evaluation of Direct Coronary Stenting) Study Group. Am J Cardiol 2001; 87:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/17\">",
"      Le Breton H, Boschat J, Commeau P, et al. Randomised comparison of coronary stenting with and without balloon predilatation in selected patients. Heart 2001; 86:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/18\">",
"      Baim DS, Flatley M, Caputo R, et al. Comparison of PRE-dilatation vs direct stenting in coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial). Am J Cardiol 2001; 88:1364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/19\">",
"      Wijns W, Verheye S, Manoharan G, et al. Angiographic, intravascular ultrasound, and fractional flow reserve evaluation of direct stenting vs. conventional stenting using BeStent2 in a multicentre randomized trial. Eur Heart J 2005; 26:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/20\">",
"      Dawkins KD, Chevalier B, Suttorp MJ, et al. Effectiveness of \"direct\" stenting without balloon predilatation (from the Multilink Tetra Randomised European Direct Stent Study [TRENDS]). Am J Cardiol 2006; 97:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/21\">",
"      Nakamura S, Colombo A, Gaglione A, et al. Intracoronary ultrasound observations during stent implantation. Circulation 1994; 89:2026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/22\">",
"      Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91:1676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/23\">",
"      Dirschinger J, Kastrati A, Neumann FJ, et al. Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation. Circulation 1999; 100:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/24\">",
"      Goldberg SL, Colombo A, Nakamura S, et al. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol 1994; 24:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/25\">",
"      Albiero R, Rau T, Schl&uuml;ter M, et al. Comparison of immediate and intermediate-term results of intravascular ultrasound versus angiography-guided Palmaz-Schatz stent implantation in matched lesions. Circulation 1997; 96:2997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/26\">",
"      Fitzgerald PJ, Oshima A, Hayase M, et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation 2000; 102:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/27\">",
"      Frey AW, Hodgson JM, M&uuml;ller C, et al. Ultrasound-guided strategy for provisional stenting with focal balloon combination catheter: results from the randomized Strategy for Intracoronary Ultrasound-guided PTCA and Stenting (SIPS) trial. Circulation 2000; 102:2497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/28\">",
"      Schiele F, Meneveau N, Vuillemenot A, et al. Impact of intravascular ultrasound guidance in stent deployment on 6-month restenosis rate: a multicenter, randomized study comparing two strategies--with and without intravascular ultrasound guidance. RESIST Study Group. REStenosis after Ivus guided STenting. J Am Coll Cardiol 1998; 32:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/29\">",
"      Mudra H, di Mario C, de Jaegere P, et al. Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS Study). Circulation 2001; 104:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/30\">",
"      Russo RJ, Silva PD, Teirstein PS, et al. A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial). Circ Cardiovasc Interv 2009; 2:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/31\">",
"      Oemrawsingh PV, Mintz GS, Schalij MJ, et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 2003; 107:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/32\">",
"      Ziada KM, Tuzcu EM, De Franco AC, et al. Intravascular ultrasound assessment of the prevalence and causes of angiographic \"haziness\" following high-pressure coronary stenting. Am J Cardiol 1997; 80:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/33\">",
"      Pijls NH, Klauss V, Siebert U, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation 2002; 105:2950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/34\">",
"      Fearon WF, Luna J, Samady H, et al. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation 2001; 104:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/35\">",
"      Berger A, Botman KJ, MacCarthy PA, et al. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 2005; 46:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/36\">",
"      Popma JJ, Ohman EM, Weitz J, et al. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest 2001; 119:321S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/37\">",
"      Pasceri V, Patti G, Nusca A, et al. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2004; 110:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/38\">",
"      Briguori C, Colombo A, Airoldi F, et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction. Eur Heart J 2004; 25:1822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/39\">",
"      Herrmann J, Lerman A, Baumgart D, et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation 2002; 106:2180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/40\">",
"      Patti G, Chello M, Pasceri V, et al. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. J Am Coll Cardiol 2006; 48:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/41\">",
"      Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 2009; 54:2157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/42\">",
"      Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007; 49:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/43\">",
"      Gibson CM, Pride YB, Hochberg CP, et al. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. J Am Coll Cardiol 2009; 54:2290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/44\">",
"      Serruys PW, de Feyter P, Macaya C, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 287:3215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/45\">",
"      Sch&ouml;mig A, Mehilli J, Holle H, et al. Statin treatment following coronary artery stenting and one-year survival. J Am Coll Cardiol 2002; 40:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/46\">",
"      Di Sciascio G, Patti G, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. J Am Coll Cardiol 2009; 54:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/47\">",
"      Abdelaal E, Rao SV, Gilchrist IC, et al. Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis. JACC Cardiovasc Interv 2013; 6:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/48\">",
"      Mavromatis K. Same-day discharge after percutaneous coronary intervention: are we ready? JACC Cardiovasc Interv 2013; 6:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24889/abstract/49\">",
"      Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1586 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-4554544F47-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24889=[""].join("\n");
var outline_f24_19_24889=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20875816\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TYPES OF STENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H689098340\">",
"      INDICATIONS FOR STENTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TECHNICAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Optimal stenting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Predilation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H546978945\">",
"      - Direct stenting without predilation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - High pressure balloon dilation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - IVUS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6097273\">",
"      - Optical coherence tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Coronary flow reserve measurements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20877214\">",
"      Hospital and operator volume",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H99799642\">",
"      Robotic PCI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20875800\">",
"      ADJUNCTIVE MEDICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Antithrombotic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Statin therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20876631\">",
"      - Before PCI",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - After PCI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20877064\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10018511\">",
"      Restenosis versus stent thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20877078\">",
"      TIMING OF DISCHARGE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SAFETY OF MRI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H614900546\">",
"      ANTIMICROBIAL PROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      RISK OF EARLY NONCARDIAC SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20875816\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H360576976\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1586\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1586|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/18/17696\" title=\"diagnostic image 1\">",
"      Coronary artery dissection IVUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1586|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/12/10434\" title=\"figure 1\">",
"      Deployment of coronary stent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1586|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/39/11901\" title=\"table 1\">",
"      Coronary artery stents approved in the United States",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10634?source=related_link\">",
"      Antiplatelet therapy after coronary artery stenting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/37/41562?source=related_link\">",
"      Antithrombotic therapy for intracoronary stent implantation: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/8/27786?source=related_link\">",
"      Antithrombotic therapy for percutaneous coronary intervention: General use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/38/27240?source=related_link\">",
"      Bypass surgery versus percutaneous intervention in the management of stable angina pectoris: Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33656?source=related_link\">",
"      Cholesterol lowering after an acute coronary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13672?source=related_link\">",
"      Clinical use of coronary artery pressure and Doppler flow measurements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29722?source=related_link\">",
"      Coronary arteriography and revascularization for unstable angina or non-ST elevation acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30970?source=related_link\">",
"      Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=related_link\">",
"      Drug-eluting intracoronary stents: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/12/6344?source=related_link\">",
"      Elective noncardiac surgery after percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/59/3002?source=related_link\">",
"      Intensity of lipid lowering therapy in secondary prevention of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/46/24298?source=related_link\">",
"      Intracoronary stent restenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/27/34234?source=related_link\">",
"      Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/20/4426?source=related_link\">",
"      Management of left main coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/22/42343?source=related_link\">",
"      Management of significant proximal left anterior descending coronary artery disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/2/32?source=related_link\">",
"      Mechanisms of benefit of lipid-lowering drugs in patients with coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/24/39298?source=related_link\">",
"      Patient information: Angioplasty and stenting for the heart (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/38/18020?source=related_link\">",
"      Patient information: Heart stents and angioplasty (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=related_link\">",
"      Periprocedural complications of percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/25/29081?source=related_link\">",
"      Possible role of long-term medical therapies to prevent restenosis following percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/62/31721?source=related_link\">",
"      Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Periprocedural management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/22/17770?source=related_link\">",
"      Use of intracoronary stents for specific coronary lesions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_19_24890="Physical abuse in children: Diagnostic evaluation and management";
var content_f24_19_24890=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Physical abuse in children: Diagnostic evaluation and management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24890/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24890/contributors\">",
"     Erin E Endom, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24890/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24890/contributors\">",
"     Daniel M Lindberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24890/contributors\">",
"     Teresa K Duryea, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/19/24890/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/19/24890/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/19/24890/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concern for suspected abuse generally arises during the evaluation of a child with an acute medical condition, often an injury. Factors that typically alert the clinician to the possibility of abuse include historical inconsistencies, suspicious findings on physical examination, and social or familial risk factors. During evaluation, it is important for the clinician to maintain a nonjudgmental attitude with a focus on treating identified injuries and assuring that the child is protected from additional harm. Key interventions include reporting of suspected child abuse and assuring that the disposition maintains the child&rsquo;s safety. Hospitalization may be required until a full social investigation occurs.",
"   </p>",
"   <p>",
"    The diagnostic evaluation for physical abuse in children will be reviewed here. The clinical manifestations of physical abuse and the differential diagnosis for suspected child abuse are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23990?source=see_link\">",
"     \"Differential diagnosis of suspected child abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The evaluation of sexual abuse and child neglect and emotional abuse are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=see_link\">",
"     \"Child neglect and emotional abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2461156\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;The identification of suspected abuse is urgently required not only to treat the current condition, but also to protect the child from a subsequent, perhaps more serious, injury. An abused child may have as much as a 50 percent chance of incurring further abuse and a 10 percent chance of dying if abuse is not detected at the initial presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the urgency of identifying suspected child abuse and the existence of mandatory reporting laws throughout the United States and in many countries around the world, child maltreatment remains consistently under identified and under reported [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Multiple factors contribute to this problem including the knowledge and expertise of healthcare practitioners, as well as variation in interpretation of what constitutes reasonable suspicion for reporting [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2461149\">",
"    <span class=\"h1\">",
"     APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;When evaluating the child who is suspected of being physically abused, it is important to remember that findings that appear to indicate abuse may result from other causes. Familiarity with the medical conditions and cultural practices that mimic child abuse and careful medical, laboratory, and radiologic evaluation can facilitate arrival at the correct diagnosis, initiation of appropriate therapy, and avoidance of the consequences of an unfounded report of suspected child abuse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23990?source=see_link&amp;anchor=H13#H13\">",
"     \"Differential diagnosis of suspected child abuse\", section on 'Cultural practices'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is rarely possible (and almost never necessary) to definitively conclude that physical abuse has occurred in the first few hours of an evaluation. In the early stages of an evaluation for abuse, physicians should use non-accusatory language that emphasizes the need for further evaluation. Examples include: &ldquo;Sometimes, when we see injuries like this, there are other injuries that can put a child at risk, and we need to test for them&rdquo;. Or &ldquo;This is more injury than we would normally expect from the event you are describing. We should be careful to determine whether there is something else medical going on, or if someone might be hurting your child&rdquo;.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MEDICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medical evaluation of suspected child abuse begins with obtaining a complete history, performing a physical examination, and observing the interactions between the parents and the child.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need to obtain a history from the child themselves should be balanced with the problems of repeated questioning in young children. Repeated questioning can be perceived by children as implying that their first answer was incorrect and may lead to a skewed or changing history. If possible, history should be obtained by individuals with specialized training in the process of obtaining history from children and ongoing peer review, such as some child protective service workers, some social workers, and some child abuse pediatricians.",
"   </p>",
"   <p>",
"    Regardless of who obtains the history, the process should begin with open-ended questions about how the injuries were sustained and then proceed to more specific questions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9\">",
"     9",
"    </a>",
"    ]. The questions should be directed first to the child if he or she is able to speak. The author usually interviews the parents and child together initially; if a significant suspicion of abuse is raised, permission is sought from the parents to interview the child alone. Most parents agree to this; whether or not it is permitted is documented in the medical record. Refusal to permit the child to be interviewed alone is considered a \"red flag\" for abuse. Social services personnel are helpful in this situation, both in assessing family dynamics and in facilitating the removal of the parents from the examination room (to interview them separately).",
"   </p>",
"   <p>",
"    If the patient is not known to the examining physician, information about past injuries, hospitalizations, and emergency department visits should be obtained, as well as information regarding the child's regular source of primary care and past medical history, including illnesses or conditions that mimic child abuse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23990?source=see_link\">",
"     \"Differential diagnosis of suspected child abuse\"",
"    </a>",
"    .) It may be necessary to contact the child's primary care provider to ascertain whether or not the child has received routine health care and immunizations as scheduled. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=see_link\">",
"     \"Child neglect and emotional abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Historical factors that raise the suspicion of abuse include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The history provided by the parent or caretaker is inconsistent with the injuries of the child (eg, a child with a history of falling from a sofa onto a carpeted floor who presents with multiple fractures, liver laceration, or traumatic brain injury) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The history is vague or lacking in detail.",
"     </li>",
"     <li>",
"      The history changes in repeated versions given by the same caretaker to different healthcare workers, or conflicting histories are given by different family members (eg, infant was burned while bathing in the",
"      <span class=\"nowrap\">",
"       sink/infant",
"      </span>",
"      was burned while bathing in the bathtub; mother was bathing",
"      <span class=\"nowrap\">",
"       her/sister",
"      </span>",
"      was bathing her) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Injury that is attributed to actions of young siblings; this account may be a cover story or may be true and related to sibling rivalry, inadequate supervision, or violence in the home [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=see_link\">",
"       \"Child neglect and emotional abuse\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31097?source=see_link\">",
"       \"Childhood exposure to intimate partner violence\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      No history is offered: \"I don't know what happened; her leg was just suddenly broken\".",
"     </li>",
"     <li>",
"      History that is inconsistent with the developmental stage of the child (eg, a four-month-old infant who turns on the hot water in the bathtub and is burned).",
"     </li>",
"     <li>",
"      Implausible history (eg, a child presents with swelling of the thigh, with a history given by the parents that \"a roach bit her\"; radiographs reveal a spiral fracture of the femur).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the general appearance of the child should include assessment of his or her clothing (eg, is it appropriate for the season? Is it clean and in good repair?). The physical examination ideally is performed with all of the child's clothing removed; the clothing can be removed sequentially (eg, examination of the upper extremities and torso while the lower body is clothed, followed by examination of the perineum and lower extremities with the torso clothed).",
"   </p>",
"   <p>",
"    Characteristic skin lesions, swelling or deformity, bone tenderness, or reluctance to use an extremity should be sought specifically, as should retinal hemorrhages, trauma to the genitals, mouth (eg, lingular or labial frenulum tears or palatal petechiae in a premobile infant), and signs of neglect (eg, malnourishment, poor hygiene). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=see_link\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=see_link\">",
"     \"Child neglect and emotional abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Findings that raise the suspicion of child abuse include [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Injuries that are not consistent with the history; this point cannot be overemphasized",
"     </li>",
"     <li>",
"      Multiple fractures in various stages of healing, or different types of injuries coexisting (eg, bruises, burns, and fractures)",
"     </li>",
"     <li>",
"      Injuries that are likely to be inflicted (eg, cigarette burns or patterned bruises)",
"     </li>",
"     <li>",
"      Evidence of poor caretaking (a child who is dirty or inadequately clothed) may raise suspicion of abuse; however, these factors correlate more strongly with neglect or poverty than with abuse, and abuse may be present in the absence of these signs",
"     </li>",
"     <li>",
"      Sudden onset of altered mental status not attributable to medical illness (eg, hypoglycemia, hypoxemia, shock) or other signs of poisoning (",
"      <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Any bruising in a child that is not yet &ldquo;cruising&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bruising to the pinna, neck, or abdomen",
"     </li>",
"     <li>",
"      Injury to the genitalia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While a careful physical examination can raise the level of concern for abuse, many abusive injuries remain hidden, even from a careful exam. Occult abdominal injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/13-15\">",
"     13-15",
"    </a>",
"    ], fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/16\">",
"     16",
"    </a>",
"    ], and brain injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/17-19\">",
"     17-19",
"    </a>",
"    ] have been well described.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Parental behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;The behavior of the parents and the interaction between family members should be observed carefully during the evaluation of the child. Certain behaviors",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    types of interaction may increase the level of suspicion for child abuse. Such behaviors include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Arguing, roughness, or violence",
"     </li>",
"     <li>",
"      Aloofness and lack of emotional interaction between parents or between parents and children",
"     </li>",
"     <li>",
"      Inappropriate response to the severity of the injury (eg, lack of appropriate concern)",
"     </li>",
"     <li>",
"      Inappropriate delay in seeking medical care [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A partial confession by the parent (eg, \"I hit him, but not that hard\") or a frank admission by parent that injury was inflicted. Such confessions occur occasionally and are an indication that the parent realizes that abuse is a problem and is seeking help.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     LABORATORY EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory evaluation should be tailored to the findings on physical examination, as well as to the specific nature or history of the injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Bleeding evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An evaluation of the child&rsquo;s coagulation may be warranted either to detect the coagulopathy that often results from traumatic brain injury, or to test for coagulopathy that could result in bruising, retinal hemorrhage or intracranial bleeding. At a minimum, bleeding studies should include a complete blood count with differential and platelet count, prothrombin and partial thromboplastin times. A more aggressive approach might include fibrinogen, thrombin time, Factors 8, 9, 11, and 13 and von Willebrand&rsquo;s testing, though many specialists choose to consult hematology before ordering more advanced testing. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3722?source=see_link\">",
"     \"Approach to the child with bleeding symptoms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anemia with an abnormal peripheral smear and cell indices may be one manifestation of neglect-associated nutritional anemia. Alterations of prothrombin",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    partial thromboplastin time are present in bleeding disorders (eg, factor deficiencies, significant hepatic injury,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/4/21578?source=see_link\">",
"     warfarin",
"    </a>",
"    or Coumadin poisoning) or in disseminated intravascular coagulation (DIC) resulting from overwhelming injury or sepsis. In the setting of DIC, bleeding time, fibrinogen level, and thrombin time may be useful as well. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chemistries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum and urine chemistries also should be obtained based upon the presentation of the patient. Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) usually are elevated in patients who have injury to the liver, whereas serum amylase or lipase may be elevated in pancreatic injury; these two injuries may be present simultaneously [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In children younger than five years who undergo consultation for physical abuse, elevation of liver enzymes may be an appropriate screen for intraabdominal injury, even in patients with no clinical signs of abdominal trauma. For example, in a multicenter observational study, 17 of 54 children with identified intraabdominal injury had no clinical findings. Fourteen of 17 had elevations in liver enzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Serum electrolytes and osmolality may be abnormal in the setting of either dehydration or water intoxication, which may occur with the forcing of fluids or in drowning with water swallowing [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/23\">",
"     23",
"    </a>",
"    ]. Serum calcium, phosphate, and alkaline phosphatase, if normal, may help to rule out bone disease (eg, osteogenesis imperfecta, rickets, hypophosphaturia) as the underlying etiology of fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26967?source=see_link\">",
"     \"Overview of rickets in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Testing for bone fragility is an area of some debate. Several theories of transient bone fragility have been proposed in the academic literature and in legal settings. While some clinical entities, such as rickets and osteogenesis imperfecta, are well-recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/24-26\">",
"     24-26",
"    </a>",
"    ], other proposed entities, such as temporary brittle bone disease, have been widely discredited [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. In cases where fractures are the only cause for concern for abuse, it is reasonable to consult with an expert in bone metabolism, such as an endocrinologist or geneticist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to consider screening with calcium, ionized calcium, phosphorus, alkaline phosphatase, parathyroid hormone, 25-hydroxy vitamin D. If there are concerns for copper deficiency or Menkes disease, measuring levels of copper or ceruloplasmin may be warranted. However, mandated reporting of suspicion for child abuse should not be delayed while awaiting consultation or results of metabolic testing in infants and children with fractures that have high specificity for abuse (eg, rib fracture, metaphyseal corner fractures). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link&amp;anchor=H14#H14\">",
"     \"Orthopedic aspects of child abuse\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinalysis should be obtained in patients who have a history or physical examination that is consistent with abdominal trauma, dehydration, or acute renal failure. Hematuria is a common finding in the setting of abdominal or genitourinary trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rhabdomyolysis can be caused by extensive muscle injury and should be considered in patients who have urine that is dipstick positive for heme, but lacks red blood cells on microscopic examination (",
"    <a class=\"graphic graphic_algorithm graphicRef55923 \" href=\"UTD.htm?22/63/23550\">",
"     algorithm 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef56337 \" href=\"UTD.htm?24/52/25419\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Patients with rhabdomyolysis typically have pigmented granular casts in the urine, a red to brown color of the urine supernatant, and a marked elevation in the plasma level of creatine kinase (CK) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=see_link&amp;anchor=H4#H4\">",
"     \"Urinalysis in the diagnosis of kidney disease\", section on 'Red to brown urine'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rhabdomyolysis may lead to oliguria, acute tubular necrosis, and renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Blood urea nitrogen and creatinine usually are elevated. Other laboratory abnormalities associated with this condition include hypocalcemia, hyperphosphatemia, and hyperuricemia. Ten to 40 percent of victims develop hyperkalemia, resulting either from potassium release from damaged cells or from renal compromise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/29\">",
"     29",
"    </a>",
"    ]. Urographic contrast agents should be avoided because they may precipitate or worsen renal failure. The management of rhabdomyolysis involves aggressive hydration and diuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/29\">",
"     29",
"    </a>",
"    ] and is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=see_link\">",
"     \"Clinical manifestations and diagnosis of rhabdomyolysis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=see_link\">",
"     \"Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Toxicology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malicious use of pharmaceuticals, is another form of child abuse, which consists of inappropriate administration of medications or other substances to children including street drugs, analgesics, sedatives (eg, benzodiazepines), ethanol, antihistamines (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/29/34256?source=see_link\">",
"     diphenhydramine",
"    </a>",
"    ), and",
"    <span class=\"nowrap\">",
"     cough/cold",
"    </span>",
"    preparations. A review of the United States National Poison Data System found 1439 cases of pharmaceutical child abuse over nine years, including 18 deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/33\">",
"     33",
"    </a>",
"    ]. In this series, half of all exposures and over 90 percent of the fatal exposures involved sedating agents, such as antihistamines, opioids, or benzodiazepines.",
"   </p>",
"   <p>",
"    Toxicology screens (serum and urine drug panels) should be obtained in children with suspected poisoning or drug exposure and in those who have symptoms compatible with ingestion (",
"    <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"     table 1",
"    </a>",
"    ) or unexplained neurologic symptoms (eg, ataxia) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9,34\">",
"     9,34",
"    </a>",
"    ]. When obtaining such tests, the clinician should primarily test for poisons that are consistent with the patient&rsquo;s symptoms (eg, testing for ethanol, opioids, benzodiazepines, barbiturates, and antihistamines in children who are lethargic). If a screening test (eg, enzyme-mediated immunoassay for drugs of abuse) is positive, then a more definitive test should be performed to confirm and quantify the amount of substance present (eg, gas",
"    <span class=\"nowrap\">",
"     chromatography/mass",
"    </span>",
"    spectrophotometry).",
"   </p>",
"   <p>",
"    It may be necessary to specifically request an assay for the poison or drug of interest because that particular substance may not be included on the routine blood and urine toxicologic screen performed by the laboratory (eg, ipecac, which commonly is used to induce vomiting in Munchausen syndrome by proxy). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36104?source=see_link\">",
"     \"Munchausen syndrome by proxy (medical child abuse)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     RADIOLOGIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar to the laboratory evaluation, the radiographic evaluation for suspected child abuse depends upon the age of the child, the presenting complaints, and the physical examination findings [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/35\">",
"     35",
"    </a>",
"    ]. When the injuries are unintentional, the radiologic evaluation may provide an alternative explanation (eg, osteopenia, skeletal dysplasia). On the other hand, when the injuries have been inflicted, the radiologic evaluation may identify the extent of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. Specific injury patterns associated with child abuse are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link\">",
"     \"Orthopedic aspects of child abuse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=see_link\">",
"     \"Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Plain radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orthogonal radiographs (anteroposterior [AP] and lateral) should be obtained of all areas of bone tenderness, swelling, deformity, or limited range of motion, and all areas that have a history or evidence of previous trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    According to the American Academy of Pediatrics (AAP) Section on Radiology [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ] and the American College of Radiology [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/39\">",
"     39",
"    </a>",
"    ], the skeletal survey (",
"    <a class=\"graphic graphic_table graphicRef82510 \" href=\"UTD.htm?15/14/15595\">",
"     table 3",
"    </a>",
"    ) is \"the method of choice for global skeletal imaging in cases of suspected child abuse\" and is mandatory for all children younger than two years of age in whom child abuse is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36,40\">",
"     36,40",
"    </a>",
"    ]. Skeletal survey is unlikely to be helpful in verbal, ambulatory children beyond the age of five years. Relative indications for obtaining a skeletal survey include (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link&amp;anchor=H8#H8\">",
"     \"Orthopedic aspects of child abuse\", section on 'Skeletal survey'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Any child less than two years of age with a concerning fracture, intraabdominal or intrathoracic injury, or concern for abusive head trauma",
"     </li>",
"     <li>",
"      Any child with severe or extensive fractures",
"     </li>",
"     <li>",
"      Any child who has a history of having one or more fractures",
"     </li>",
"     <li>",
"      A history in the child or family of \"soft\" or easily broken bones",
"     </li>",
"     <li>",
"      Household contact of an abused child who is less than two years of age, regardless of physical findings (see",
"      <a class=\"local\" href=\"#H4721692\">",
"       'Identifying injuries in other children at risk'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A proper skeletal survey requires several views and special technique as well as interpretation by a skeletal survey-experienced radiologist. One study of skeletal survey techniques published in 2004 found widespread lack of adherence to published guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/41\">",
"     41",
"    </a>",
"    ]. Several experts recommend the addition of the Towne&rsquo;s view to increase sensitivity for skull fractures, and the evaluation for Wormian bones, which are more commonly seen among children with osteogenesis imperfecta and other metabolic bone disease.",
"   </p>",
"   <p>",
"    The importance of the skeletal survey in children undergoing evaluation for physical abuse is demonstrated by an observational study of 703 children; 11 percent had abnormalities, primarily fractures, and the highest frequency of positive surveys was seen in infants under six months of age and in infants and children with an apparent life-threatening event, seizure, or suspected abusive head trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/16\">",
"     16",
"    </a>",
"    ]. Of the 76 patients with positive skeletal surveys, the results of the survey directly led to the diagnosis of abuse in 50 percent of cases.",
"   </p>",
"   <p>",
"    The skeletal survey and its comparison with radionuclide bone scans in the detection of fractures are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link&amp;anchor=H6#H6\">",
"     \"Orthopedic aspects of child abuse\", section on 'Radiographic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Neurologic injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous system injuries may occur in children who are shaken violently or who are injured by high-energy forces that are associated with impact. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Intracranial injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging (computed tomography [CT] or magnetic resonance imaging [MRI]) can be used to detect these injuries, to follow their evolution, and to evaluate the development of secondary complications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The goal of neuroimaging in the acute setting is the rapid detection of treatable conditions (eg, increased intracranial pressure). Subsequent evaluation should be directed toward a complete characterization of the extent and age of the injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/44\">",
"     44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23178?source=see_link\">",
"     \"Approach to neuroimaging in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neuroimaging should be performed in all infants in whom nonaccidental head injury is suspected, and perhaps in all children younger than six months of age in whom any inflicted injury is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/17,40,45\">",
"     17,40,45",
"    </a>",
"    ]. In one study, 51 children younger than two years who were admitted to an urban children's hospital with injuries suspicious for child abuse and a normal neurologic examination underwent neuroimaging if they met any of the following \"high-risk\" criteria: rib fractures; multiple fractures; facial injury; or age less than six months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/17\">",
"     17",
"    </a>",
"    ]. Occult neurologic injury was detected in 19 patients (37 percent, 95% CI, 24 to 50 percent) and would have been missed by skeletal survey alone in five children, all of whom were less than six months of age. Ophthalmologic examination was performed in 14 of the 19 children, but no retinal hemorrhages were detected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Unenhanced CT of the head (with brain and bone windows) is the preferred imaging study for initial evaluation in suspected cases of inflicted head trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36,40,46,47\">",
"     36,40,46,47",
"    </a>",
"    ]. Evidence of rotational",
"    <span class=\"nowrap\">",
"     acceleration/deceleration",
"    </span>",
"    injury may be present, with diffuse subdural hemorrhage, subarachnoid hemorrhage, focal cortical contusions,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    brain swelling. If the child has suffered impact to the head, contact injuries, including skull fractures, scalp hematomas, and cerebral contusions may be identified. Although head CT has the highest sensitivity and specificity for diagnosing acute hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/47\">",
"     47",
"    </a>",
"    ], some studies have demonstrated that the initial head CTs of abused infants may appear normal, only showing pathology on follow-up scans [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Nonetheless, emergent head CTs permit identification of any injury requiring emergent surgical attention [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/47\">",
"     47",
"    </a>",
"    ]. In addition, certain findings are more consistent with intentional head trauma and review by an experienced pediatric neuroradiologist may be helpful to diagnosis this condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=see_link&amp;anchor=H11#H11\">",
"     \"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children\", section on 'Computed tomography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29464?source=see_link&amp;anchor=H12#H12\">",
"     \"Intracranial subdural hematoma in children: Clinical features, evaluation, and management\", section on 'Abusive head injury'",
"    </a>",
"    .).",
"   </p>",
"   <p>",
"    On the other hand, noncontrast brain MRI is superior in documenting the full extent of intracranial injuries and may demonstrate small extraaxial hemorrhages, parenchymal contusions, evidence of shearing injury, and posterior fossa abnormalities missed by CT [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36,50-52\">",
"     36,50-52",
"    </a>",
"    ]. Diffusion-weighted imaging may detect cerebral ischemia not readily perceived on conventional CT and MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/53\">",
"     53",
"    </a>",
"    ]. Even when injuries are identified with both CT and MRI, the enhanced visual clarity of the latter often makes for a better scan. However, many critically ill infants may not be able to undergo MRI. In addition, because MRI sometimes fails to identify acute subarachnoid or subdural hemorrhage, it is traditionally obtained three to seven days after injury, rather than at the time of admission [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ]. MRI is the preferred modality for identifying subacute and chronic injury, because it has the highest sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23178?source=see_link\">",
"     \"Approach to neuroimaging in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Skull fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both CT and plain radiographs may be required to fully evaluate skull fractures in children who are suspected of having been abused. Basilar skull fractures are evaluated best with CT, whereas fractures of the cranial vault are detected more reliably by plain radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/46,51\">",
"     46,51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=see_link\">",
"     \"Skull fractures in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Spinal fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertebral compression and spinous process fractures usually are visualized on plain radiographs. Complex fractures should be evaluated by thin-section CT. Fractures associated with clinical findings of spinal cord or nerve root injury (uncommon to rare in abuse) should be evaluated by MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link\">",
"     \"Evaluation of cervical spine injuries in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Thoracic injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt thoracic trauma, whether intentional or unintentional, may result in pulmonary contusion, pneumothorax, pleural effusion, rib fractures, vascular, and tracheobronchial injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ]. Thus, the radiographic evaluation for thoracic injury sustained in child abuse is the same as that for thoracic injury caused by unintentional trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/54\">",
"     54",
"    </a>",
"    ]. Chest and cervical spine radiographs typically are obtained in the initial assessment. They are followed by CT scan with intravenous contrast if the patient is stable and internal chest injury is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ]. This evaluation is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link&amp;anchor=H6#H6\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\", section on 'Evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=see_link&amp;anchor=H18#H18\">",
"     \"Initial evaluation and stabilization of children with thoracic trauma\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fresh rib fractures may be difficult to detect on plain chest or rib films. They may become evident only after callus formation develops 10 to 14 days into the healing process [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. A four-view chest radiograph that includes oblique views increases the number of rib fractures detected in possible child abuse victims [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. Radionuclide bone scan or Fluorine-18 NaF positron emission tomography may assist in cases where plain film findings are absent or equivocal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Traumatic esophageal perforation and subsequent formation of an abscess are visualized as prevertebral swelling with subcutaneous emphysema on plain radiographs. Contrast esophagography reveals extravasation of contrast material through the rupture, whereas CT with oral contrast delineates the characteristic findings of extraluminal air and fluid and esophageal thickening, as well as extravasation and abscess formation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/62\">",
"     62",
"    </a>",
"    ]. Traumatic esophageal perforation is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3495?source=see_link&amp;anchor=H7#H7\">",
"     \"Intrathoracic injuries in children\", section on 'Esophageal injury'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=see_link&amp;anchor=H3#H3\">",
"     \"Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis\", section on 'Esophageal injury'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pneumothorax and hemothorax may result from abusive injuries and are visible on plain radiographs as air and blood in the pleural space, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40793?source=see_link\">",
"     \"Spontaneous pneumothorax in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Abuse-related chylothorax is visualized on chest radiograph as unilateral (commonly left-sided) or bilateral pleural fluid collections. Abusive chylothorax may be accompanied by rib fractures, and detailed rib films as well as a complete skeletal survey (",
"    <a class=\"graphic graphic_table graphicRef82510 \" href=\"UTD.htm?15/14/15595\">",
"     table 3",
"    </a>",
"    ) should be performed if chylothorax is thought to be inflicted. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=see_link&amp;anchor=H5#H5\">",
"     \"Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis\", section on 'Chylothorax'",
"    </a>",
"    .) Subdural hematoma and retinal hemorrhages should be considered and appropriate evaluation for these findings should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Abdominal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt abdominal trauma, whether intentional or unintentional, may result in injury to the liver, spleen, pancreas, kidney, adrenal glands, mesentery, or intestines. Children who are abused have an increased occurrence of pancreatic injuries and duodenal hematomas, injuries that often are difficult to detect on the basis of clinical or radiologic evaluation. Blunt abdominal injury is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link\">",
"     \"Overview of blunt abdominal trauma in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Making the diagnosis of intraabdominal injuries in the absence of a history of trauma can be difficult, particularly when the presentation is delayed, as occurs commonly in abusive injuries. In addition, initial laboratory analysis (CBC, electrolytes, liver and pancreatic enzymes) may be normal soon after injury, and physical examination may be relatively nonspecific (eg, diffuse abdominal tenderness with hypoactive bowel sounds), or even normal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Plain flat and upright radiographs of the abdomen typically are obtained in the initial evaluation. These studies may demonstrate intraperitoneal fluid, extraluminal air, ileus, and scoliosis, but such findings are present in fewer than 40 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/64\">",
"     64",
"    </a>",
"    ]. Plain radiographs are followed by CT scan if the patient is stable and internal injury is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT of the abdomen with intravenous contrast is more sensitive than are plain radiographs in detecting signs of injury to the liver, spleen, intestines, kidneys, or major blood vessels. CT is considered the first-line evaluation for significant injury [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36,64-66\">",
"     36,64-66",
"    </a>",
"    ]. Intravenous contrast is used routinely to define injuries to the vasculature, liver, spleen, pancreas, adrenal glands, and kidneys. Simultaneous bone windows can detect associated injuries to the ribs, spine, or pelvis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of blunt abdominal trauma in children\", section on 'Radiologic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The practice of using abdominal ultrasound with or without serial measurements of liver enzymes in place of CT is not recommended. In one group of 55 children with abdominal injuries who had both ultrasound and CT, the ultrasound was normal in 7 (13 percent) children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/19\">",
"     19",
"    </a>",
"    ]. Liver enzymes almost universally improve, whether or not an injury is present. In one cohort of 118 children with known hepatic injury and multiple measurements of liver enzymes, 112 (95 percent) had immediate and permanent improvement of their liver enzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/67\">",
"     67",
"    </a>",
"    ]. While these approaches may decrease the amount of radiation exposure to the child, they are insensitive and less likely to identify inflicted injury. The injuries detected are unlikely to be clinically significant, yet are important as red flags for future abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4437991\">",
"    <span class=\"h1\">",
"     OPHTHALMOLOGIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consultation with an ophthalmologist for a complete dilated indirect funduscopic examination is recommended in all children younger than five years of age in whom abusive head trauma is strongly suspected. The examination should take place within 24 to 72 hours so that transient retinal changes are not missed. The detection of retinal hemorrhages may be a crucial step in the identification of child abuse and appropriately direct additional evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=see_link&amp;anchor=H5#H5\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\", section on 'Ophthalmology consultation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Retinal findings, such as retinal hemorrhages, may be detected by any physician who is familiar with such hemorrhages and has experience with direct funduscopy (",
"    <a class=\"graphic graphic_figure graphicRef61192 \" href=\"UTD.htm?34/42/35497\">",
"     figure 1",
"    </a>",
"    ). Clinicians other than ophthalmologists may also dilate the pupils to improve their view (",
"    <a class=\"graphic graphic_table graphicRef57408 \" href=\"UTD.htm?40/33/41499\">",
"     table 4",
"    </a>",
"    ). However, detection of intraocular abnormalities is optimized by ophthalmology consultation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=see_link&amp;anchor=H4#H4\">",
"     \"Child abuse: Eye findings in children with abusive head trauma (AHT)\", section on 'Initial eye examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evidence suggests that the frequency of retinal hemorrhages is low in young children with normal imaging and no evidence of head trauma on physical examination:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective observational study of 282 children under two years of age with no traumatic brain injury on neuroimaging and undergoing evaluation for physical abuse, retinal hemorrhage was found in 9 children (3.2 percent), but only 2 patients (0.7 percent [95% CI 0.1-2.5 percent]) had eye findings characteristic for abuse [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective validation study of low risk criteria for retinal hemorrhage, none of the 141 children with normal mental status, no head or facial bruising, normal neuroimaging (computed tomography or magnetic resonance imaging of the head), and normal or simple linear fractures on plain radiographs of the skull had retinal hemorrhage on dilated indirect funduscopic examination [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, an eye examination by an ophthalmologist is not invasive and seems warranted, if available, and suspicion for abusive head trauma is high enough that a skeletal survey or neuroimaging is obtained. Furthermore, in children who do not receive eye examination by an ophthalmologist, determination that there are no significant findings of child abuse should only occur after consultation with a child abuse specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the medical, laboratory, and radiologic evaluations are complete and the child's urgent medical needs are addressed, the evaluating physician must determine the level of suspicion for child abuse (ie, whether the injuries appear to have been intentionally inflicted or unintentionally acquired) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/70\">",
"     70",
"    </a>",
"    ]. If consultation with a multidisciplinary team (eg, social worker, nurse, physician with more extensive experience in the management of child abuse) is available, it should be obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9,70\">",
"     9,70",
"    </a>",
"    ]. Such consultations provide an opportunity for:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Information-sharing",
"     </li>",
"     <li>",
"      Joint decision-making",
"     </li>",
"     <li>",
"      Planning an approach to the family and subsequent case-management",
"     </li>",
"     <li>",
"      Mutual support",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Hospitalization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for hospitalization of the abused child depends upon several factors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9,71\">",
"     9,71",
"    </a>",
"    ]. Hospitalization may be warranted for the treatment of certain conditions (eg, burns, ingestion, intracerebral injury). In addition, hospitalization may be indicated for the safety of the child [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9,71\">",
"     9,71",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the child is considered to be unsafe in the care of the parent until after Child Protective Services (CPS) makes an evaluation",
"     </li>",
"     <li>",
"      If the response of CPS or another community agency will be delayed unacceptably",
"     </li>",
"     <li>",
"      If a protective environment where the child can be evaluated by knowledgeable consultants needs to be provided (if such specialized services are not available in the community)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Mandated reporting",
"    </span>",
"    &nbsp;&mdash;&nbsp;In many parts of the world (including the US, UK, and Australia), a report to appropriate governmental authorities is also required for cases of suspected abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9,70,72\">",
"     9,70,72",
"    </a>",
"    ]. Reporting of child abuse and neglect is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link\">",
"     \"Child abuse: Social and medicolegal issues\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Documentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Documenting each step of the evaluation and management of suspected child abuse is important. The record of the history should be as factual as possible; conclusions and impressions should not be included [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/9\">",
"     9",
"    </a>",
"    ]. Statements from the child or parents should be recorded as direct quotations to lessen the chance that they will be considered \"hearsay\". Injuries should be described in as much detail as possible. Sketches",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    high-quality photographs are helpful in documenting extensive injuries. However, in some states, parental permission must be obtained before photographs may be taken. The social and medicolegal issues of child abuse are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link\">",
"     \"Child abuse: Social and medicolegal issues\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4721692\">",
"    <span class=\"h2\">",
"     Identifying injuries in other children at risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Identifying and ensuring evaluation of all other children currently sharing a household with an abused child is an essential component of case management. When the index case is severe or results in death, child maltreatment among other children in the household has been reported in up to 72 percent of siblings [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/73,74\">",
"     73,74",
"    </a>",
"    ]. In many settings, the ultimate responsibility for this task of identifying and evaluating household contacts falls to the governmental authority responsible for child abuse investigation in collaboration with a child abuse team. However, these children sometimes are brought to the emergency department by social services or have accompanied the abused child.",
"   </p>",
"   <p>",
"    Children over the age of two years should undergo a complete history and careful physical examination looking for clinical findings suggesting abuse. A limited number of these patients may need additional studies (eg, plain radiographs) to assess acute injuries. In addition to history and physical examination, we suggest that children two years of age or younger who are household contacts of an abused child receive a skeletal survey to screen for abusive fractures. In a prospective, multicenter observational study of 479 household contacts of abused children undergoing evaluation by child abuse teams, at least one abusive fracture was found in 12 percent of the 134 contacts who were two years of age or younger and bruises concerning for abuse were noted in 2 percent of children five years of age and younger [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/75\">",
"     75",
"    </a>",
"    ]. None of the fractures detected by screening were clinically suspected or had associated physical findings. Twin siblings were at a clinically significant increased risk of fracture (OR 20). (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Plain radiographs'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Computed tomography (CT) of the head in all household contacts six months of age or younger has been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/75\">",
"     75",
"    </a>",
"    ]. However, evidence is limited regarding the yield of this approach and whether the radiation exposure is justified. Head CT is indicated in these infants and young children despite a normal neurologic examination if they have abusive fractures, retinal hemorrhages, or other physical findings of abuse. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=see_link&amp;anchor=H11#H11\">",
"     \"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children\", section on 'Computed tomography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link&amp;anchor=H7#H7\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4721684\">",
"    <span class=\"h1\">",
"     EMERGENCY DEPARTMENT SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Observational studies suggest that 0.2 to 2 percent of children presenting for emergency care are victims of child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/76-78\">",
"     76-78",
"    </a>",
"    ]. Retrospective case series indicate that abused children who remain undetected have a substantial risk for continued abuse (up to 50 percent) and death (10 to 30 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/1,79-81\">",
"     1,79-81",
"    </a>",
"    ]. Nurse-administered screening of all children coming to the emergency department (ED) using a checklist based upon historical features",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a head to toe skin examination has been promoted as a means of improving detection and avoiding missed cases of child abuse. Such screening is mandatory in some jurisdictions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/76,82\">",
"     76,82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Observational studies indicate that the use of nurse-administered screening checklists in the emergency department (ED) does significantly increase the frequency with which children are referred for evaluation of child abuse and may increase detection, depending upon the setting, as indicated by the following evidence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a systematic review of outcomes of child abuse screening reported in four observational studies (8987 children seen in the ED), the rate of detection of suspected cases of abuse increased by a weighted mean of 180 percent after introduction of a nurse-administered checklists [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/82\">",
"       82",
"      </a>",
"      ]. However, increased identification of confirmed cases of child abuse was not shown in any study.",
"     </li>",
"     <li>",
"      In another observational study that evaluated a nurse-administered checklist and head to toe skin assessment on screening and detection rates of child abuse in 104,028 pediatric ED patients at seven hospitals, 37,404 checklists were completed and 306 patients were referred for additional evaluation by a child abuse team (183 with a completed checklist) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/76\">",
"       76",
"      </a>",
"      ]. During the study, screening rates increased from 20 to 67 percent although ED screening was legally mandated during the study. Child abuse was confirmed in 243 (79 percent of referrals, 0.2 percent of all pediatric ED patients). Child abuse was detected in 0.5 percent of screened children versus 0.1 percent of unscreened children. The odds of child abuse detection among screened versus unscreened children were clinically significantly greater (OR 4.9). However, the odds of child abuse detection were not significantly different among screened or unscreened children evaluated in the hospital where clinicians had the most experience with identifying abuse (OR 1.0).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary prevention programs directed toward populations at risk for child maltreatment have demonstrated some success, especially the Nurse Family Partnership and parental education regarding abusive head trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/83-89\">",
"     83-89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In randomized trials, the Nurse Family Partnership program significantly reduced the number of verified reports of child abuse and neglect in the group that received prenatal and early childhood home visitation by nurses compared with the group that did not in multiple distinct geographic settings. Furthermore, when paraprofessionals were used instead of nurses, the beneficial effect was cut in half. Successful implementation of a nurse visitation program requires careful attention to participant attrition [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/86\">",
"     86",
"    </a>",
"    ]. In contrast, a home visitation intervention to prevent recurrence of child abuse found a higher recurrence of physical abuse or neglect in the intervention group [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A mandatory parent training program, instituted in the Buffalo, New York region, decreased the annual incidence of abusive head trauma by 47 percent. This program consisted of an educational session to parents on crying and abusive head trauma, a video presentation entitled \"Portrait of Promise\", and a commitment that parents signed stating that they would not shake their baby [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/87,91\">",
"     87,91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In an educational trial using the Period of PURPLE crying program, the 1279 mothers who received the intervention reported a greater knowledge of infant crying and were almost twice as likely to walk away from their baby when frustrated by crying as the 920 mothers in the control group [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/92\">",
"     92",
"    </a>",
"    ]. Although not directly correlated with reduction in abusive behavior, this study provides a primary prevention strategy that is based on sound principles of pediatric development and is inexpensive to implement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/19/24890/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resources that may be helpful in the evaluation and management of suspected child abuse are listed in the provided table (",
"    <a class=\"graphic graphic_table graphicRef57326 graphicRef69110 \" href=\"UTD.htm?12/7/12414\">",
"     table 5A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22841427\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The identification of suspected abuse is urgently required not only to treat the current condition, but also to protect the child from a subsequent, perhaps more serious, injury. An abused child may have as much as a 50 percent chance of incurring further abuse and a 10 percent chance of dying if abuse is not detected at the initial presentation. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Historical factors that raise the suspicion of abuse include (see",
"      <a class=\"local\" href=\"#H3\">",
"       'History'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The history provided by the parent or caretaker is inconsistent with the injuries of the child (eg, a child with a history of falling from a sofa onto a carpeted floor who presents with multiple fractures, serious intraabdominal injury, or severe head trauma).",
"     </li>",
"     <li>",
"      The history is vague or lacking in detail.",
"     </li>",
"     <li>",
"      The history changes in repeated versions given by the same caretaker to different healthcare workers, or conflicting histories are given by different family members (eg, infant was burned while bathing in the",
"      <span class=\"nowrap\">",
"       sink/infant",
"      </span>",
"      was burned while bathing in the bathtub; mother was bathing",
"      <span class=\"nowrap\">",
"       her/sister",
"      </span>",
"      was bathing her).",
"     </li>",
"     <li>",
"      Injury that is attributed to actions of siblings; this account may be a cover story or may be true and related to sibling rivalry, inadequate supervision, or violence in the home. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=see_link\">",
"       \"Child neglect and emotional abuse\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31097?source=see_link\">",
"       \"Childhood exposure to intimate partner violence\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      No history is offered: \"I don't know what happened; her leg was just suddenly broken.\"",
"     </li>",
"     <li>",
"      History that is inconsistent with the developmental stage of the child (eg, a four-month-old infant who turns on the hot water in the bathtub and is burned).",
"     </li>",
"     <li>",
"      Implausible history (eg, a child presents with swelling of the thigh, with a history given by the parents that \"a roach bit her\"; radiographs reveal a spiral fracture of the femur).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical examination findings that raise the suspicion of child abuse include (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Injuries that are not consistent with the history; this point cannot be overemphasized",
"     </li>",
"     <li>",
"      Multiple fractures in various stages of healing, or different types of injuries coexisting (bruises, burns, fractures)",
"     </li>",
"     <li>",
"      Injuries that are likely to be inflicted (eg, cigarette burns, patterned bruises)",
"     </li>",
"     <li>",
"      Evidence of poor caretaking (a child who is dirty or inadequately clothed) may raise suspicion of abuse; however, these factors correlate more strongly with neglect or poverty than with abuse, and abuse may be present in the absence of these signs",
"     </li>",
"     <li>",
"      Behavioral disturbances in the child, who may be too compliant with the examiner, especially during painful or disturbing examination of injuries, or the rectum or genitalia; outgoing and \"pseudomature\" for his or her age; withdrawn, passive, or depressed; violent; or hyperactive",
"     </li>",
"     <li>",
"      Sudden onset of altered mental status not attributable to medical illness (eg, hypoglycemia, hypoxemia, shock) or other signs of poisoning (",
"      <a class=\"graphic graphic_table graphicRef71268 \" href=\"UTD.htm?43/6/44140\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The laboratory evaluation should be tailored to the findings on physical examination, as well as to the specific nature or history of the injury. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The skeletal survey (",
"      <a class=\"graphic graphic_table graphicRef82510 \" href=\"UTD.htm?15/14/15595\">",
"       table 3",
"      </a>",
"      ) is mandatory for all children younger than two years of age in whom child abuse is suspected. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Plain radiographs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Unenhanced CT of the head (with brain and bone windows) is the preferred imaging study for initial evaluation in suspected cases of inflicted head trauma. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Neurologic injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      After complete evaluation and treatment of the child's urgent medical needs, the evaluating clinician should determine the level of suspicion for child abuse (ie, whether the injuries appear to have been intentionally inflicted or unintentionally acquired). If consultation with a multidisciplinary child abuse team (eg, social worker, nurse, physician with more extensive experience in the management of child abuse) is available, it should be obtained. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In many parts of the world (including the US, UK, and Australia), a report to appropriate governmental authorities is also required for cases of suspected abuse. Reporting of child abuse and neglect is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link\">",
"       \"Child abuse: Social and medicolegal issues\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hospitalization may be warranted for the treatment of certain conditions (eg, burns, ingestion, intracerebral injury) and may also be indicated for the safety of the child. Children currently sharing a household with an abused child warrant prompt evaluation for possible abuse. In addition to history and physical examination, we suggest that children two years of age or younger who are household contacts of an abused child also receive a skeletal survey. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Hospitalization'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4721692\">",
"       'Identifying injuries in other children at risk'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/1\">",
"      Saade, DN, Simon, HK, Greenwald, M. Abused children. Missed opportunities for recognition in the ED. Acad Emerg Med 2002; 9:524.",
"     </a>",
"    </li>",
"    <li>",
"     Rosen, LA, Wissow, LS. Effects of maltreatment on the child. In: Child Advocacy for the Clinician: An Approach to Child Abuse and Neglect, Williams and Wilkins, Baltimore 1990. p.12.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/3\">",
"      Loder RT, Bookout C. Fracture patterns in battered children. J Orthop Trauma 1991; 5:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/4\">",
"      Vandeven AM, Newton AW. Update on child physical abuse, sexual abuse, and prevention. Curr Opin Pediatr 2006; 18:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/5\">",
"      Flaherty EG, Sege R. Barriers to physician identification and reporting of child abuse. Pediatr Ann 2005; 34:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/6\">",
"      Dubow SR, Giardino AP, Christian CW, Johnson CF. Do pediatric chief residents recognize details of prepubertal female genital anatomy: a national survey. Child Abuse Negl 2005; 29:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/7\">",
"      Trokel M, Waddimba A, Wadimmba A, et al. Variation in the diagnosis of child abuse in severely injured infants. Pediatrics 2006; 117:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/8\">",
"      Levi BH, Brown G. Reasonable suspicion: a study of Pennsylvania pediatricians regarding child abuse. Pediatrics 2005; 116:e5.",
"     </a>",
"    </li>",
"    <li>",
"     Ludwig, S. Child abuse. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher, GR, Ludwig, S, Henretig, FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.1761.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/10\">",
"      Hettler J, Greenes DS. Can the initial history predict whether a child with a head injury has been abused? Pediatrics 2003; 111:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/11\">",
"      Sugar NF, Taylor JA, Feldman KW. Bruises in infants and toddlers: those who don't cruise rarely bruise. Puget Sound Pediatric Research Network. Arch Pediatr Adolesc Med 1999; 153:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/12\">",
"      Carpenter RF. The prevalence and distribution of bruising in babies. Arch Dis Child 1999; 80:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/13\">",
"      Lindberg D, Makoroff K, Harper N, et al. Utility of hepatic transaminases to recognize abuse in children. Pediatrics 2009; 124:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/14\">",
"      Lane WG, Dubowitz H, Langenberg P. Screening for occult abdominal trauma in children with suspected physical abuse. Pediatrics 2009; 124:1595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/15\">",
"      Coant PN, Kornberg AE, Brody AS, Edwards-Holmes K. Markers for occult liver injury in cases of physical abuse in children. Pediatrics 1992; 89:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/16\">",
"      Duffy SO, Squires J, Fromkin JB, Berger RP. Use of skeletal surveys to evaluate for physical abuse: analysis of 703 consecutive skeletal surveys. Pediatrics 2011; 127:e47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/17\">",
"      Rubin DM, Christian CW, Bilaniuk LT, et al. Occult head injury in high-risk abused children. Pediatrics 2003; 111:1382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/18\">",
"      Laskey AL, Holsti M, Runyan DK, Socolar RR. Occult head trauma in young suspected victims of physical abuse. J Pediatr 2004; 144:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/19\">",
"      Karam O, La Scala G, Le Coultre C, Chardot C. Liver function tests in children with blunt abdominal traumas. Eur J Pediatr Surg 2007; 17:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/20\">",
"      Wagner GN. Crime scene investigation in child-abuse cases. Am J Forensic Med Pathol 1986; 7:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/21\">",
"      Wood J, Rubin DM, Nance ML, Christian CW. Distinguishing inflicted versus accidental abdominal injuries in young children. J Trauma 2005; 59:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/22\">",
"      Cameron CM, Lazoritz S, Calhoun AD. Blunt abdominal injury: simultaneously occurring liver and pancreatic injury in child abuse. Pediatr Emerg Care 1997; 13:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/23\">",
"      Arieff AI, Kronlund BA. Fatal child abuse by forced water intoxication. Pediatrics 1999; 103:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/24\">",
"      Schilling S, Wood JN, Levine MA, et al. Vitamin D status in abused and nonabused children younger than 2 years old with fractures. Pediatrics 2011; 127:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/25\">",
"      Paterson CR. Vitamin D deficiency and fractures in childhood. Pediatrics 2011; 127:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/26\">",
"      Botash AS, Sills IN, Welch TR. Calciferol deficiency mimicking abusive fractures in infants: is there any evidence? J Pediatr 2012; 160:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/27\">",
"      Mendelson KL. Critical review of 'temporary brittle bone disease'. Pediatr Radiol 2005; 35:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/28\">",
"      Sprigg A. Temporary brittle bone disease versus suspected non-accidental skeletal injury. Arch Dis Child 2011; 96:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/29\">",
"      Schwengel D, Ludwig S. Rhabdomyolysis and myoglobinuria as manifestations of child abuse. Pediatr Emerg Care 1985; 1:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/30\">",
"      Mukherji SK, Siegel MJ. Rhabdomyolysis and renal failure in child abuse. AJR Am J Roentgenol 1987; 148:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/31\">",
"      Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988; 148:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/32\">",
"      Grossman RA, Hamilton RW, Morse BM, et al. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med 1974; 291:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/33\">",
"      Yin S. Malicious use of pharmaceuticals in children. J Pediatr 2010; 157:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/34\">",
"      Wiley CC, Wiley JF 2nd. Pediatric benzodiazepine ingestion resulting in hospitalization. J Toxicol Clin Toxicol 1998; 36:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/35\">",
"      Section on Radiology, American Academy of Pediatrics. Diagnostic imaging of child abuse. Pediatrics 2009; 123:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/36\">",
"      Section on Radiology, American Academy of Pediatrics. Diagnostic imaging of child abuse. Pediatrics 2009; 123:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/37\">",
"      Ablin DS, Sane SM. Non-accidental injury: confusion with temporary brittle bone disease and mild osteogenesis imperfecta. Pediatr Radiol 1997; 27:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/38\">",
"      Merten DF, Radkowski MA, Leonidas JC. The abused child: a radiological reappraisal. Radiology 1983; 146:377.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Radiology. ACR Standards for Skeletal Surveys in Children. Resolution 22. American College of Radiology, Reston, VA,1997. p.23.",
"    </li>",
"    <li>",
"     American College of Radiology. ACR appropriateness criteria. Suspected physical abuse - child. file://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/SuspectedPhysicalAbuseChild.pdf (Accessed on August 06, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/41\">",
"      Kleinman PL, Kleinman PK, Savageau JA. Suspected infant abuse: radiographic skeletal survey practices in pediatric health care facilities. Radiology 2004; 233:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/42\">",
"      Ball WS Jr. Nonaccidental craniocerebral trauma (child abuse): MR imaging. Radiology 1989; 173:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/43\">",
"      Sinal SH, Ball MR. Head trauma due to child abuse: serial computerized tomography in diagnosis and management. South Med J 1987; 80:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/44\">",
"      Merten DF, Osborne DR, Radkowski MA, Leonidas JC. Craniocerebral trauma in the child abuse syndrome: radiological observations. Pediatr Radiol 1984; 14:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/45\">",
"      Datta S, Stoodley N, Jayawant S, et al. Neuroradiological aspects of subdural haemorrhages. Arch Dis Child 2005; 90:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/46\">",
"      American Academy of Pediatrics Committee on Child Abuse and Neglect: Shaken baby syndrome: inflicted cerebral trauma. Pediatrics 1993; 92:872.",
"     </a>",
"    </li>",
"    <li>",
"     Diagnostic Imaging of Child Abuse, 2nd, Kleinman, P (Eds), Mosby, Boston 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/48\">",
"      Feldman KW, Bethel R, Shugerman RP, et al. The cause of infant and toddler subdural hemorrhage: a prospective study. Pediatrics 2001; 108:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/49\">",
"      Dias MS, Backstrom J, Falk M, Li V. Serial radiography in the infant shaken impact syndrome. Pediatr Neurosurg 1998; 29:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/50\">",
"      Sato Y, Yuh WT, Smith WL, et al. Head injury in child abuse: evaluation with MR imaging. Radiology 1989; 173:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/51\">",
"      Duhaime AC, Christian CW, Rorke LB, Zimmerman RA. Nonaccidental head injury in infants--the \"shaken-baby syndrome\". N Engl J Med 1998; 338:1822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/52\">",
"      Alexander RC, Schor DP, Smith WL Jr. Magnetic resonance imaging of intracranial injuries from child abuse. J Pediatr 1986; 109:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/53\">",
"      Atwal GS, Rutty GN, Carter N, Green MA. Bruising in non-accidental head injured children; a retrospective study of the prevalence, distribution and pathological associations in 24 cases. Forensic Sci Int 1998; 96:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/54\">",
"      Sivit CJ, Taylor GA, Eichelberger MR. Visceral injury in battered children: a changing perspective. Radiology 1989; 173:659.",
"     </a>",
"    </li>",
"    <li>",
"     Albert, MJ, Drvaric, DM. Injuries resulting from pathologic forces: child abuse. In: Pediatric Fractures: A Practical Approach to Assessment and Treatment, MacEwan, GD, Kasser, JR, Heinrich, SD (Eds), Williams and Wilkins, Baltimore 1993. p.388.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/56\">",
"      Anilkumar A, Fender LJ, Broderick NJ, et al. The role of the follow-up chest radiograph in suspected non-accidental injury. Pediatr Radiol 2006; 36:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/57\">",
"      Kocher MS, Kasser JR. Orthopaedic aspects of child abuse. J Am Acad Orthop Surg 2000; 8:10.",
"     </a>",
"    </li>",
"    <li>",
"     Kleinman, PK. Skeletal imaging strategies. In: Diagnostic Imaging of Child Abuse, Kleinman, PK (Eds), Mosby, St. Louis 1998. p.237.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/59\">",
"      Hansen KK, Prince JS, Nixon GW. Oblique chest views as a routine part of skeletal surveys performed for possible physical abuse--is this practice worthwhile? Child Abuse Negl 2008; 32:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/60\">",
"      Smith FW, Gilday DL, Ash JM, Green MD. Unsuspected costo-vertebral fractures demonstrated by bone scanning in the child abuse syndrome. Pediatr Radiol 1980; 10:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/61\">",
"      Drubach LA, Sapp MV, Laffin S, Kleinman PK. Fluorine-18 NaF PET imaging of child abuse. Pediatr Radiol 2008; 38:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/62\">",
"      Morzaria S, Walton JM, MacMillan A. Inflicted esophageal perforation. J Pediatr Surg 1998; 33:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/63\">",
"      Geismar SL, Tilelli JA, Campbell JB, Chiaro JJ. Chylothorax as a manifestation of child abuse. Pediatr Emerg Care 1997; 13:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/64\">",
"      Beckmann KR, Nozicka CA. Small bowel perforation: an unusual presentation for child abuse. J Am Osteopath Assoc 2000; 100:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/65\">",
"      Raissaki M, Veyrac C, Blondiaux E, Hadjigeorgi C. Abdominal imaging in child abuse. Pediatr Radiol 2011; 41:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/66\">",
"      Hilmes MA, Hernanz-Schulman M, Greeley CS, et al. CT identification of abdominal injuries in abused pre-school-age children. Pediatr Radiol 2011; 41:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/67\">",
"      Baxter AL, Lindberg DM, Burke BL, et al. Hepatic enzyme decline after pediatric blunt trauma: a tool for timing child abuse? Child Abuse Negl 2008; 32:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/68\">",
"      Thackeray JD, Scribano PV, Lindberg DM. Yield of retinal examination in suspected physical abuse with normal neuroimaging. Pediatrics 2010; 125:e1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/69\">",
"      Li S, Mitchell E, Fromkin J, Berger RP. Retinal hemorrhages in low-risk children evaluated for physical abuse. Arch Pediatr Adolesc Med 2011; 165:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/70\">",
"      Saperia J, Lakhanpaul M, Kemp A, et al. When to suspect child maltreatment: summary of NICE guidance. BMJ 2009; 339:b2689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/71\">",
"      Medical necessity for the hospitalization of the abused and neglected child. American Academy of Pediatrics. Committee on Hospital Care and Committee on Child Abuse and Neglect. Pediatrics 1998; 101:715.",
"     </a>",
"    </li>",
"    <li>",
"     Goldman, J, Salus, MK, Wolcott, D, Kennedy, KY. A Coordinated Response to Child Abuse and Neglect: The Foundation for Practice. Office on Child Abuse and Neglect (DHHS), Washington, DC, 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/73\">",
"      Hamilton-Giachritsis CE, Browne KD. A retrospective study of risk to siblings in abusing families. J Fam Psychol 2005; 19:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/74\">",
"      Baldwin JA, Oliver JE. Epidemiology and family characteristics of severely-abused children. Br J Prev Soc Med 1975; 29:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/75\">",
"      Lindberg DM, Shapiro RA, Laskey AL, et al. Prevalence of abusive injuries in siblings and household contacts of physically abused children. Pediatrics 2012; 130:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/76\">",
"      Louwers EC, Korfage IJ, Affourtit MJ, et al. Effects of systematic screening and detection of child abuse in emergency departments. Pediatrics 2012; 130:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/77\">",
"      Pless IB, Sibald AD, Smith MA, Russell MD. A reappraisal of the frequency of child abuse seen in pediatric emergency rooms. Child Abuse Negl 1987; 11:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/78\">",
"      Palazzi S, de Girolamo G, Liverani T, IChilMa (Italian Child Maltreatment study group). Observational study of suspected maltreatment in Italian paediatric emergency departments. Arch Dis Child 2005; 90:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/79\">",
"      Jenny C, Hymel KP, Ritzen A, et al. Analysis of missed cases of abusive head trauma. JAMA 1999; 281:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/80\">",
"      King WK, Kiesel EL, Simon HK. Child abuse fatalities: are we missing opportunities for intervention? Pediatr Emerg Care 2006; 22:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/81\">",
"      Ravichandiran N, Schuh S, Bejuk M, et al. Delayed identification of pediatric abuse-related fractures. Pediatrics 2010; 125:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/82\">",
"      Louwers EC, Affourtit MJ, Moll HA, et al. Screening for child abuse at emergency departments: a systematic review. Arch Dis Child 2010; 95:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/83\">",
"      Olds DL, Eckenrode J, Henderson CR Jr, et al. Long-term effects of home visitation on maternal life course and child abuse and neglect. Fifteen-year follow-up of a randomized trial. JAMA 1997; 278:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/84\">",
"      Olds DL, Kitzman H, Cole R, et al. Effects of nurse home-visiting on maternal life course and child development: age 6 follow-up results of a randomized trial. Pediatrics 2004; 114:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/85\">",
"      Olds DL, Robinson J, O'Brien R, et al. Home visiting by paraprofessionals and by nurses: a randomized, controlled trial. Pediatrics 2002; 110:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/86\">",
"      Olds DL, Sadler L, Kitzman H. Programs for parents of infants and toddlers: recent evidence from randomized trials. J Child Psychol Psychiatry 2007; 48:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/87\">",
"      Krugman SD, Lane WG, Walsh CM. Update on child abuse prevention. Curr Opin Pediatr 2007; 19:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/88\">",
"      Macmillan HL, Wathen CN, Barlow J, et al. Interventions to prevent child maltreatment and associated impairment. Lancet 2009; 373:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/89\">",
"      Altman RL, Canter J, Patrick PA, et al. Parent education by maternity nurses and prevention of abusive head trauma. Pediatrics 2011; 128:e1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/90\">",
"      MacMillan HL, Thomas BH, Jamieson E, et al. Effectiveness of home visitation by public-health nurses in prevention of the recurrence of child physical abuse and neglect: a randomised controlled trial. Lancet 2005; 365:1786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/91\">",
"      Dias MS, Smith K, DeGuehery K, et al. Preventing abusive head trauma among infants and young children: a hospital-based, parent education program. Pediatrics 2005; 115:e470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/92\">",
"      Barr RG, Barr M, Fujiwara T, et al. Do educational materials change knowledge and behaviour about crying and shaken baby syndrome? A randomized controlled trial. CMAJ 2009; 180:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/19/24890/abstract/93\">",
"      Jenny C. Preventing head trauma from abuse in infants. CMAJ 2009; 180:703.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6600 Version 15.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-14.112.150.12-37D25D05A2-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24890=[""].join("\n");
var outline_f24_19_24890=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22841427\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2461156\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2461149\">",
"      APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MEDICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Parental behavior",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      LABORATORY EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Bleeding evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chemistries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Toxicology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      RADIOLOGIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Plain radiographs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Neurologic injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Intracranial injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Skull fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Spinal fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Thoracic injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Abdominal injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4437991\">",
"      OPHTHALMOLOGIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Hospitalization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Mandated reporting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Documentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4721692\">",
"      Identifying injuries in other children at risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4721684\">",
"      EMERGENCY DEPARTMENT SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22841427\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6600\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6600|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?22/63/23550\" title=\"algorithm 1\">",
"      Etiology of red urine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6600|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/42/35497\" title=\"figure 1\">",
"      Retinal hemorrhage types",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6600|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/6/44140\" title=\"table 1\">",
"      Poisoning syndromes - toxidromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/52/25419\" title=\"table 2\">",
"      Heme negative red urine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/14/15595\" title=\"table 3\">",
"      Standard skeletal survey",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/33/41499\" title=\"table 4\">",
"      Ophthalmalogic dilating agents abusive head trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/20/4429\" title=\"table 5A\">",
"      Child abuse neglect resources A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/25/1437\" title=\"table 5B\">",
"      Child abuse neglect resources B",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23178?source=related_link\">",
"      Approach to neuroimaging in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/40/3722?source=related_link\">",
"      Approach to the child with bleeding symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=related_link\">",
"      Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=related_link\">",
"      Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20602?source=related_link\">",
"      Child abuse: Eye findings in children with abusive head trauma (AHT)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/2/19497?source=related_link\">",
"      Child abuse: Injuries of the thorax; abdomen; retroperitoneum; and pelvis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=related_link\">",
"      Child neglect and emotional abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31097?source=related_link\">",
"      Childhood exposure to intimate partner violence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/20/25929?source=related_link\">",
"      Clinical features, diagnosis, and treatment of disseminated intravascular coagulation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/55/32632?source=related_link\">",
"      Clinical manifestations and diagnosis of rhabdomyolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23990?source=related_link\">",
"      Differential diagnosis of suspected child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=related_link\">",
"      Evaluation of cervical spine injuries in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=related_link\">",
"      Evaluation of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/63/27640?source=related_link\">",
"      Initial evaluation and stabilization of children with thoracic trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29464?source=related_link\">",
"      Intracranial subdural hematoma in children: Clinical features, evaluation, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3495?source=related_link\">",
"      Intrathoracic injuries in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/16/36104?source=related_link\">",
"      Munchausen syndrome by proxy (medical child abuse)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33768?source=related_link\">",
"      Overview of blunt abdominal trauma in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26967?source=related_link\">",
"      Overview of rickets in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21847?source=related_link\">",
"      Prevention and treatment of heme pigment-induced acute kidney injury (acute renal failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13704?source=related_link\">",
"      Skull fractures in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/53/40793?source=related_link\">",
"      Spontaneous pneumothorax in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=related_link\">",
"      Urinalysis in the diagnosis of kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_19_24891="2011 soft lens use by type";
var content_f24_19_24891=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F57327&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F57327&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    2011 soft lens use by type (United States and worldwide)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        United States",
"       </td>",
"       <td class=\"subtitle1\">",
"        Worldwide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Silicone/hydrogel",
"       </td>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        34",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other soft daily wear",
"       </td>",
"       <td>",
"        17",
"       </td>",
"       <td>",
"        26",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Daily disposable",
"       </td>",
"       <td>",
"        16",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Soft extended wear",
"       </td>",
"       <td>",
"        14",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rigid gas permeable",
"       </td>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orthokeratology",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Numbers are percent of total soft lens market.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Morgan PB, Woods CA, Tranoudis IG, et al. International contact lens prescribing in 2011. Contact lens spectrum 2012. Available at:",
"     <a href=\"file://www.clspectrum.com/articleviewer.aspx?articleID=106551\">",
"      file://www.clspectrum.com/articleviewer.aspx?articleID=106551",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24891=[""].join("\n");
var outline_f24_19_24891=null;
var title_f24_19_24892="ADA criteria DKA HHS";
var content_f24_19_24892=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F72111&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F72111&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria for diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"       DKA",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"       HHS",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Mild",
"      </td>",
"      <td class=\"subtitle2\">",
"       Moderate",
"      </td>",
"      <td class=\"subtitle2\">",
"       Severe",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Plasma glucose (mg/dL)",
"      </td>",
"      <td>",
"       &gt;250",
"      </td>",
"      <td>",
"       &gt;250",
"      </td>",
"      <td>",
"       &gt;250",
"      </td>",
"      <td>",
"       &gt;600",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Arterial pH",
"      </td>",
"      <td>",
"       7.25-7.30",
"      </td>",
"      <td>",
"       7.00-7.24",
"      </td>",
"      <td>",
"       &lt;7.00",
"      </td>",
"      <td>",
"       &gt;7.30",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serum bicarbonate (mEq/L)",
"      </td>",
"      <td>",
"       15-18",
"      </td>",
"      <td>",
"       10 to &lt;15",
"      </td>",
"      <td>",
"       &lt;10",
"      </td>",
"      <td>",
"       &gt;18",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Urine ketones*",
"      </td>",
"      <td>",
"       Positive",
"      </td>",
"      <td>",
"       Positive",
"      </td>",
"      <td>",
"       Positive",
"      </td>",
"      <td>",
"       Small",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Serum ketones*",
"      </td>",
"      <td>",
"       Positive",
"      </td>",
"      <td>",
"       Positive",
"      </td>",
"      <td>",
"       Positive",
"      </td>",
"      <td>",
"       Small",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Effective serum osmolality (mOsm/kg)&bull;",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"      <td>",
"       &gt;320",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Anion gap&Delta;",
"      </td>",
"      <td>",
"       &gt;10",
"      </td>",
"      <td>",
"       &gt;12",
"      </td>",
"      <td>",
"       &gt;12",
"      </td>",
"      <td>",
"       Variable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alteration in sensoria or mental obtundation",
"      </td>",
"      <td>",
"       Alert",
"      </td>",
"      <td>",
"       Alert/drowsy",
"      </td>",
"      <td>",
"       Stupor/coma",
"      </td>",
"      <td>",
"       Stupor/coma",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Nitroprusside reaction method.",
"     <br>",
"      &bull; Calculation: 2[measured Na (mEq/L)] + glucose (mg/dL)/18.",
"      <br>",
"       &Delta; Calculation: (Na+) - (Cl- + HCO3-) (mEq/L). See text for details.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; 2006 American Diabetes Association From Diabetes Care Vol 29, Issue 12, 2006. Information updated from Kitabchi, AE, Umpierrez, GE, Miles, JM, Fisher, JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009; 32:1335.",
"     <br>",
"      Reprinted with permission from the American Diabetes Association.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24892=[""].join("\n");
var outline_f24_19_24892=null;
var title_f24_19_24893="Circumcision info sheet A";
var content_f24_19_24893=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65954%7EOBGYN%2F74975&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65954%7EOBGYN%2F74975&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Circumcision",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        What is circumcision?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        When a baby boy is born, the end of his penis is covered with a layer of skin called the foreskin. This extra skin has two main functions: to protect the end of the penis, or glans, and to provide sexual pleasure. Circumcision is a procedure that surgically removes this foreskin. Importantly, this is not required by law, nor is it medically necessary - it is a choice made by you, the parent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The procedure typically takes anywhere from 10 to 20 minutes, and is performed by a doctor, usually in the nursery before the child goes home after delivery.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Is it painful?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recent studies have confirmed that babies do experience pain during this procedure, but steps can be taken to minimize this. Often an injection of anesthesia into the base of the penis is given to block the feelings of pain. Also, a sugar solution can be administered to the baby by mouth. Most importantly, you should discuss pain control with the doctor who is performing the circumcision.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        What are the benefits of circumcision?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Circumcision is often performed for religious or cultural reasons. In English speaking, Western countries, most males are circumcised. Conversely, circumcisions for non-religious reasons are rarely done in Europe, Asia, or South America. In the past, up to 90% of all males born in the United States were circumcised, but today that number has dropped to 60%. The reasons that some parents choose to have their son circumcised: they want their son to look like other males in their family, or are afraid they will be picked on for looking different. Also, circumcision has been suggested as a good way to keep the penis clean. This has not been shown to be true.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Some research has shown some medical benefits to having your son circumcised. As an example, some studies have shown a small decrease in risk of urinary infections early in life. And, while extremely rare, the risk of penile cancer is lower in circumcised males. It also may decrease the risk of sexually transmitted diseases. Occasionally a child will need a circumcision later in life because of cancer, injury or infection. Circumcisions may reduce some of these risks but fewer than 10% of uncircumcised males will need the procedure later in life.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        What are the risks of circumcision?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All surgical procedures, including circumcision, carry risks. These include excessive bleeding, infection, problems with anesthesia, and a poor cosmetic result. Rarely there can be injury to the glans, shaft or urethra of the penis. All of these complications, however, are very rare and affect only a small number of babies.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Circumcision",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Care of the uncircumcised penis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If your child has not been circumcised, his foreskin will usually separate from the glans in about three to five years. Once this has occurred, the foreskin should be pulled back and washed with soap and water. Dry the foreskin, before pulling it forward. The foreskin should never be forcibly pulled back when there is resistance.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Care of the circumcised penis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        After your son's circumcision is done, a Vaseline gauze dressing is usually applied. Remove this gauze after 24 hours. To do this, apply Vaseline to the gauze with a diaper change, then at the next diaper change take the gauze off. Clean the circumcision site with warm water and a cotton ball once or twice a day. Apply Vaseline for several days. This helps keep the area clean and keeps the wound site from adhering to the diaper. At first, the penis will appear red. In a few days, you may notice a soft yellow scab. This is normal and will go away in a few days. During this process, you will need to watch for redness, swelling, bleeding or drainage that does not go away. If you notice any of these, notify your baby's doctor. Usually, the circumcision needs no further care once it has healed. Sometimes a small portion of foreskin remains attached to the glans. It should be pulled back gently and cleaned during bath time.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Special situations that influence circumcisions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        There are a few situations that may cause a circumcision to be delayed. Babies that are born too soon need to wait until they grow before they can have a circumcision. Sometimes a baby is born with a birth defect of the penis. In this circumstance, a urologist may be consulted before the circumcision can be performed. If there is a history of bleeding disorders, your baby's doctor may ask you to wait until the risk of bleeding can be determined.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        When do I need to make a decision?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        This decision is best made before your baby is born. The procedure can be performed at the hospital or as an outpatient procedure with local anesthesia up to 12 months of age. Many pediatricians' offices, however, are not equipped for this procedure. Thereafter, this procedure usually requires general anesthesia. As a parent, it is strongly recommended that you discuss this topic with your baby's doctor before making the final decision.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24893=[""].join("\n");
var outline_f24_19_24893=null;
var title_f24_19_24894="Emmetropia normal refraction";
var content_f24_19_24894=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/79812/emmetrop_conv.mp4?title=Emmetropia+normal+refraction\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Emmetropia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 198px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An emmetropic eye has no refractive error. The image of an object twenty feet or more away (optical infinity) is focused on the retina.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: the University of Michigan Kellogg Eye Center, file://www.kellogg.umich.edu.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24894=[""].join("\n");
var outline_f24_19_24894=null;
var title_f24_19_24895="Syndromes associated with OSA";
var content_f24_19_24895=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Syndromes that have obstructive sleep apnea as a finding and the factors that contribute to the obstruction",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Micro- gnathia",
"       </td>",
"       <td class=\"subtitle1\">",
"        Maxillary Hypoplasia (Small Nasal Capsule)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Choanal Atresia or Stenosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cranial Base Anomalies",
"       </td>",
"       <td class=\"subtitle1\">",
"        Hypotonia of Pharynx",
"       </td>",
"       <td class=\"subtitle1\">",
"        Macro-glossia",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other Anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Achondroplasia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Apert",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beckwith-Wiedemann",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Camptomelic and dysplasia",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Tracheal, bronchial cartilage anomalies;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerebro- costo- mandibular",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Charge association",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Crouzon",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Tracheal ring anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        De Lange",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diastrophic dysplasia",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Femoral dysgenesis",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal alcohol",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetal hydantoin",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Freeman-Sheldon",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Multiple contractures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fronto- metaphyseal dysplasia",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Cranial overgrowth; scoliosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hallermann-Streiff",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemifacial microsomia",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Pharyngeal asymmetry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Holo- prosencephaly sequence",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Larsen's",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Connective tissue dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Marshall- Smith",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nager",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Otopalato- digital",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pfeiffer",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Tracheal ring anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prader-Willi",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pykno- dysostosis",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Robin sequence (isolated)",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rubinstein-Taybi",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shprintzen",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Laryngeal web; retrognathia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shprintzen-Goldberg",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spondylo- epiphyseal dysplasia",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stickler",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Short genioglossus; soft tracheal cartilage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Storage disorders (lysosomal, etc)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Steinert",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Myotonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Townes",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treacher Collins",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Turner",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        Short neck",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"8\" rowspan=\"1\">",
"        Chromosome disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Down's (Trisomy 21)",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Trisomy 18",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        CNS anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Trisomy 13",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        CNS anomalies; holoprosencephaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Trisomy 4p",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        CNS anomalies; short neck",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        6q-deletion",
"       </td>",
"       <td class=\"sublist_other\">",
"        +",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"       <td class=\"sublist_other\">",
"        CNS anomalies; laryngeal dysfunction",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sher AE. Obstructive sleep apnea syndrome: a complex disorder of the upper airway. Otolaryngol Clin North Am 1990; 23:593. Copyright &copy;1990 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_19_24895=[""].join("\n");
var outline_f24_19_24895=null;
